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ABSTRACT
The effects of the a-adrenergic agonist clonidine on the
flexor reflex in intact and spinalized rats
John Herr Kehne, B.A., Amherst College
M.A., University of Massachusetts, Ph.D., University of Massachusetts
Directed by: Professor Jerrold Meyer
A series of experiments investigated the effects of the a-adrenergic
agonist clonidine on the flexor reflex (FR) in spinalized and intact
rats. Clonidine produced a dose-dependent facilitation of the FR in
spinalized rats, whereas it produced a dose-dependent inhibition in
intact rats (Expt. 1). The facilitatory effect was completely blocked
by pretreatment with the
-adrenergic antagonist prazosin, but not by
the ot2-adrenergic antagonist piperoxane whereas the inhibitory effect
was blocked by piperoxane but not by prazosin (Expt. 2).
Intraventricular, but not intrathecal, administration of the
a2-adrenergic agonist oxymetazoline produced a dose-dependent
depression of the FR in intact rats (Expt. 3) that was reversed by
piperoxane (Expt. 4). Two hypotheses that would explain the shift in
the effects of clonidine from a2-adrenergically mediated inhibition in
intact rats to a^-adrenergically mediated excitation in spinalized rats
were tested. An increase in the number of a^-adrenergic receptor sites
(Expt. 6) and a delayed onset of the excitatory effect of clonidine
following transection (Expt. 5) were consistent with the rapid
development of -adrenergic supersensitivity. However, halothane was
shown to have residual effects which interfered with the expression
of
iv
the excitatory effect of clonidine (Expt. 8) and intrathecal
administration of the a^-adrenergic agonist phenylephrine failed to
produce an enhanced FR response in spinalized rats relative to intact
rats (Expt. 7). Blockade of spinal impulse flow with intrathecal
procaine (Expt. 9) or by spinal ligation (Expt. 10) (in which the
residual effects of halothane were ruled out) was found to produce an
immediate shift of the FR from inhibition to excitation. The magnitude
of clonidine 's facilitatory effect was similar fifteen minutes or two
hours following ligation (Expt. 11); furthermore, no change in
a-| -adrenergic receptor binding was seen at these two times (Expt. 12).
These data indicate that the shift in clonidine 's effects from
inhibition in the normal rat to excitation in the spinalized rat is
attributable to removal of a supraspinal a^-adrenergic inhibitory
system which, when activated in the intact rat, prevents the expression
of the excitatory effect of
-adrenergic stimulation. Finally,
clonidine still depressed the FR in decerebrate rats (Expt. 13),
suggesting that the supraspinal site mediating clonidine 's inhibitory
action is located in the caudal regions of the brainstem.
V
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CHAPTER I
NEUROCHEMICAL MODULATION OF REFLEX BEHAVIOR
The science of psychopharraacology is concerned with analyzing the
effects of drugs on behavior. Drugs are utilized as tools for
manipulating the activities of specific neurotransmitter systems. The
resultant behavioral changes that accompany drug administration can
thus give a clue as to how neurotransmitter systems modulate behavior.
In the course of its rather brief development, psychopharmacology
has focused on the brain mechanisms that underlie drug induced changes
in behavior. With the refinement of anatomical and biochemical
techniques for identifying discrete neurotransmitter pathways in the
central nervous system (CNS) has come a realization that many of the
identified transmitter systems that project throughout the brain also
project into the spinal cord.
Norepinephrine (NE), serotonin (5-HT), and even dopamine
(DA)-containing neurons have specific spinal projections from their
cell bodies in the brainstem (Ungerstedt, 1972; Nygren and Olson, 1977;
Bowker et al., 1981). In addition, other neurotransmitters, such as
the inhibitory transmitters X-aminobutyric acid (GABA) and glycine, are
known to be released by spinal interneurons (Barber and McLaughlin,
1980). Therefore, it is quite reasonable to think that the spinal cord
might be an important site where neural modulation by various
neurochemical systems takes place.
In fact, physiologists and pharmacologists have been the first to
recognize that a great deal of neurochemical modulation takes place
at
1
2the level of the spinal cord (see Fed. Proc. Symposium, 40, 13).
Spinal reflexes have been extensively utilized for evaluating the
effects of drugs, primarily because they provide relatively simple
stimulus-response systems (e.g. Jurna, 1981). The neural machinery for
the spinal reflex, the basic unit of motor organization in the CNS, is
present at the segmental level and can be analyzed pharmacologically,
electrophysiologically, and functionally. Importantly, the spinal cord
can be analyzed in the absence of 'higher' neural influences from the
brain using the spinally-transected preparation. By using drugs as
tools to alter transmission in neurochemical systems that are either
extrinsic (i.e. that descend from the brain) or intrinsic to the spinal
cord, one can determine how specific neural systems modulate reflex
transmission at the spinal level.
The information provided by this type of analysis may be of
general significance in providing information relevant to the study of
complex behaviors that require sensorimotor integration at the
supraspinal level. Since the spinal cord is the final output for most
behavior, it is reasonable to think that neurochemical modulation that
occurs at spinal levels could exert important, general influences on
behavior. For example, learning an avoidance task may require
conditioning that takes place in the brain, yet because the performance
of the actual response requires activation of a-motoneurons in the
spinal cord, the expression of the response may be altered by activity
in a spinal neurochemical system.
The purpose of this chapter is to review behavioral, anatomical,
pharmacological and electrophysiological studies which have
3investigated the spinal function of the major identified neurochemical
systems (norepinephrine, dopamine, serotonin, GABA, acetylcholine,
glycine). Though the focus will be predominantly on spinal reflex
behavior, mention will be made of studies that have implicated these
neurochemical systems in the modulation of other types of spinally-
mediated motor activity and in sensory processing (pain). It is hoped
that this approach will acquaint the reader with the complexity and
potential importance of neurochemical modulation in the spinal cord.
Descending Serotonergic Neurons
Anatomy . The spinally-projecting 5-HT pathways have been classically
associated with the more caudally-located medullary raphe nuclei
(B^-B^) (using the terminology of Dahlstrom and Fuxe, 1965). The raphe
magnus projects via the dorsolateral funiculus to the substantia
gelatinosa (an area shown to be critical in the modulation and
transmission of sensory information—especially pain signals— to the
brain). 5-HT axons from the raphe pallidus and raphe obscurus descend
in the lateral and ventral funiculi to innervate the ventral horn, as
well as the sympathetic lateral column (cf. Gilbert et al., 1982).
Recent work using combined horseradish peroxidase and 5-HT
immunocytochemistry has shown a heretofore unknown descending
projection originating from more rostrally located 5-HT nuclei in the
midbrain reticular formation (Bowker et al . , 1981). Interestingly,
this projection appears to innervate only the cervical cord.
Measurements of 5-HT levels following transection of the spinal
4cord at the cervical level have shown that most, if not all, of the
intrinsic spinal 5-HT is contained within descending fibers (Carlsson
et al., 1963). However, a recent report has indicated that a small
number of 5-HT neurons may be intrinsic to the spinal cord, at least in
monkeys (La Motte et al., 1981).
Modulation of spinal reflexes .
Whole limb extensor reflexes . The early work of Anden and his
colleagues suggested that increasing spinal 5-HT transmission resulted
in an enhancement of hindlimb extensor reflexes. Hindlimb extension
was semi-quantitatively estimated by observing the reflex response that
resulted from pinching the base of the tail of the rat. Using this
measure, it vjas found that administration of the 5-HT precursor
5-hydroxytryptophan (in combination with the monoamine oxidase
inhibitor nialimide) produced a dose-dependent increase in the extensor
reflex. Other drugs purported to have a 5-HT agonist or mixed-agonist
properties, i.e. LSD, N, N-dimethyltryptamine (DMT; 10-50 mg/kg), and
psilocybin (1-50 mg/kg) also produced an enhancement of extensor
reflexes (Anden et al., 1967; Anden et al., 1971). The effect of 5-HTP
was blocked by pretreatment with a decarboxylase inhibitor, whereas
pretreatment with the a-noradrenergic receptor blocker
phenoxybenzamine, or the dopamine receptor blocker haloperidol had no
effect. More recently, the 5-HT agonist 5-methoxy-dimethyltryptainine
(5-MeODMT) has also been found to increase the extensor reflex using
this model (Fuxe et al., 1972; Fuxe et al., 1974).
5MhQl3. limk Xiexor reneges. In their studies on the hindlimb extension
reflex, Anden and his colleagues commented that spinal 5-HT exerted
little or no influence on flexor reflexes. Using a semi-quantitative
evaluation scale (observer estimation of the magnitude and force of
toe-pinch induced flexor withdrawal), it was reported tht 5-HTP (plus
the peripheral decarboxylase inhibitor nialimide), LSD, and
methysergide all failed to produce a clear increase of the flexor
reflex. Certainly, any effects seen were little in comparison to the
activation seen following norepinephrine stimulation (see NE section).
More recently, using different techniques of measurement and
different means for eliciting the flexor reflex, it has been reported
that 5-HT activation facilitates this reflex. Nozaki et al. (1977)
measured whole limb contraction by attaching the hindlimb to a force
transducer. Flexor contraction was elicited by presenting electrical
stimuli through electrodes implanted subcutaneously in the plantar
region of the hindpaw of the rat. LSD (10 ug/kg) increased flexor
contraction (Nozaki et al., 1977); similar findings were earlier
reported in spinal cats (Little et al., 1957). This facilitation was
blocked by pretreatment with the 5-HT antagonist cyproheptadine, which
by itself has no effect on the reflex (Nozaki et al., 1977).
Interestingly, 5-HTP produced a facilitation in rats that had been
chronically, but not acutely transected, a finding attributed to the
development of denervation supersensitivity in the chronically
transected preparation (see section on supersensitivity). Tryptamine
was also found to activate the whole limb flexor reflex, and this
effect was reversed by cyproheptadine.
6Individual, fj-exor ipuscXes. Maj and his coworkers have carried out
numerous studies utilizing a single flexor muscle in the hindleg (the
tibialis anterior) to study 5-HT modulation of the flexor reflex. The
single muscle was dissected free from the limb by cutting the tendon,
and tied to a force transducer for measurement of the contraction. The
eliciting stimulus was a short duration (5 msec) electrical pulse to
the plantar region of the hindpaw. Using this preparation, it has been
shown that increasing 5-HT transmission in the spinal cord results in a
facilitation of flexor reflex activity.
Administration of LSD (2 - 10 ug/kg) increased the contraction of
the tibialis anterior flexor reflex, and this increase was blocked by
cyproheptadine or metergoline (Maj et al., 1976). This activation was
not attenuated by treatment with the a-noradrenergic receptor blocker
phenoxybenzamine, nor the dopamine receptor blocker haloperidol (Maj et
al., 1976). Surprisingly, hovjever, the "atypical" neuroleptic
clozapine and the potent DA antagonist pimozide were effective in
blocking the LSD effect, leading the authors to conclude that these
agents possessed some 5-HT antagonist properties.
LSD facilitation of the flexor reflex has also been reported using
a different flexor muscle, the semitendinosus (cf. unpublished
findings, Maj et al., 1976). Thus, LSD produced qualitatively similar
responses on both single muscle and whole limb flexor reflexes, with
the exception of the studies using the toe-pinch induced reflex.
Other 5-HT agonists have been reported to facilitate the single
muscle flexor reflex. Mescaline was found to produce a rapid onset,
long duration (60 - 90 minutes) increase in the tibialis anterior
7response (Maj et al., 1977) as did quipazine (Palider and Rawlow,
1977). Both of these effects were blocked by cyproheptadine.
Furthermore, using electromyographic (EMG) discharge in the psoas
flexor muscle as their measure of flexor activation, Austin et al.
(1976) found that the 5-HT agonist 5-MeODMT produced a short-lasting,
rapid onset facilitation.
Using a similar preparation in the cat as that used by Maj et al.
in the rat, Marley and Vane (1967) reported that 5-HT (0.5 - 2.0
mg/kg), DMT (2.0 mg/kg) and tryptamine produced increases in the
tibialis flexor reflex. The higher doses of tryptamine and 5-HT
produced a biphasic effect on the reflex, that is, an initial increase
followed by depression and then recovery. The depression was not
attributable to actions of metabolites, since infusions of various
metabolites were without effect. The tryptamine effect was blocked by
methysergide (but not phenoxybenzamine ) and increased by nialimide.
Drugs purported to enhance the terminal release of 5-HT, e.g.
para-chloroamphetamine (PCA) and fenfluramine, were also found to
produce an increase in the amplitude of the tibialis anterior flexor
reflex (Maj et al., 1976; Maj et al., 1977), and these responses were
cyproheptadine or metergoline reversible. Again, however, complete
specificity was not found, in that phenoxybenzamine and clozapine (but
not haloperidol) blocked the excitatory effects of the two drugs.
Clozapine has been reported to have some a-adrenergic antagonist
actions (Bartholini, 1973), a property in common with phenoxybenzamine
that might explain their abilities to block the effects of PCA and
fenfluramine. In support of this idea, pimozide (which has both
dopamine and norepinephrine antagonist properties), but not
haloperidol, blocked the effect of fenfluramine.
Finally, adminstration of 5-HT precursors 5-HTP and 1
-tryptophan
were found to increase the tibialis anteror flexor reflex (Maj et al.,
1976), and these effects were blocked by cyproheptadine. The increase
following 5-HTP administration is in contrast to the negative results
reported using the whole limb flexor reflex (Nozaki et al., 1977).
Both preparations were acutely spinalized, suggesting that time after
transection was not a factor. The different effects obtained may
represent an instance in which a drug effect on the single muscle and
whole limb response is not qualitatively similar.
Stretch reflexes . The previous sections have described the effects of
increasing 5-HT activity on flexion and extension reflexes that are
elicited by cutaneous stimuli (pressure, electrical stimulation of skin
receptors). These reflexes are mediated through polysynaptic circuits.
Reflex activation of muscles can also be achieved through stretch-
induced activation of the "A-loop". This loop involves a simple two-
neuron, monosynaptic pathway from the primary (la) afferent to the
X-motoneuron. Stretching a muscle results in compensatory contraction
of the muscle through a feedback loop from the muscle spindle to the
a-motoneuron. Importantly, the sensitivity of the stretch reflex can
be altered by changing the sensitivity of the muscle spindle through
activation of the fusimotor fiber system ( "A-efferent" system).
Activation of X-motoneurons in the ventral horn activates the fusimotor
fibers of the muscle spindle, changing the sensitivity of the spindle
9such that, when the muscle is stretched, there is a greater discharge
in the la afferent fibers and (via a monosynaptic activation of
a-motoneurons) a greater contraction of the muscle. The ,\ -motoneurons
can be activated by neurons that descend from the brain, thereby
changing the "bias" on the muscle spindle and increasing the
excitability of the muscle without causing direct contraction of the
muscle.
Although tryptamine was reported to be ineffective in increasing
the tail-pinch induced extensor reflex (Anden et al., 1971), it has
been found effective in increasing the patellar stretch reflex in man
(Martin and Sloan, 1970). Similarly, the tendon jerk reflex in spinal
cats has been reported to show an enhancement following administration
of 10 ug/kg LSD (Martin and Sloan, 1970). One possible site of drug
action is at the level of the ct -motoneuron (5-HT modulation could
directly, or indirectly through interneurons influence the activity of
the a-motoneuron) . Alternatively, 5-HT activation could cause a
facilitation of A-motoneuron activity which would activate the
"X-loop". As will be seen later, there is evidence for 5-HT modulation
at both the level of the a- and X -motoneuron.
Following transection of the spinal cord, there is a loss of the
tonic stretch reflex in the extensor soleus muscle. Ahlman and
Grillner (1971) have shown that administration of 5-HTP restores this
reflex, and concomitantly produces a "resting discharge" in static
X-efferent motoneurons in the ventral horn of the cord. This
activation is reversed by 5-HT antagonists.
Recently, Commissiong and Sedgwick (1979) have suggested that
10
spinal 5-HT exerts inhibitory effects on the stretch reflex of the
extensor gastrocnemius-soleus complex, in that 5-HTP administration
produced a potent, dose-dependent inhibitory effect on the stretch
reflex. Importantly, this work was carried out in decerebrate animals,
in contrast to the studies by Ahlman and Grillner, which were carried
out in spinalized preparations. Furthermore, it was reported that 1-
DOPA produced a biphasic effect on the stretch reflex (activation
followed by inhibition), and that prior treatment with 5,6-DHT
abolished the late inhibitory, but not the early excitatory effect.
This finding provided further support for the hypothesis that
activation of the 5-HT system in the decerebrate animal resulted in a
depression of the stretch reflex.
Whether the opposite functional effects of 5-HT transmission in
the decerebrate and spinal animal are due to additional actions of
5-HTP not present in the spinal preparation, or whether they are due to
a fundamental change in the mechanism of action of 5-HTP remains to be
determined.
Modulation of other behaviors .
Post-decapitation reflex . The post-decapitation kicking response (PDR)
is a series of rapid, alternating flexions and extensions of the
hindlimbs that begin immediately following decapitation and last for
approximately 20 seconds. The occurrence of the PDR has been
attributed to two fundamentally different mechanisms. On the one hand,
it has been suggested that the reflexive kicking results from a
11
transection-induced "release" from tonic supraspinal inhibition (Kamut
and Sheth, 1971). Alternatively, the transection might serve to
stimulate cerebro-spinal fiber tracts, causing a release of transmitter
in the spinal cord that activates the neural circuitry for the PDR
(Eichbaum et al., 1975). Currently, there is no evidence that would
conclusively support one of these hypotheses.
Spinal 5-HT appears to exert a slight modulatory influence on the
PDR in that prior depletion of 5-HT with 5 , 7-dihdroxytryptamine
(5,7-DHT) or blockade of 5-HT synthesis with PCPA has been shown to
reduce the strength of the PDR (Pappas et al., 1980). These authors
suggested that this result was consistent with data suggesting 5-HT
facilitation of extensor reflexes (Anden et al., 1968); that is, the
effect of decreased 5-HT transmission was to reduce the hindlimb
extension component of the PDR. In light of the considerable data
indicating that 5-HT facilitates flexor responses as well, this
suggests that a reduction of the PDR is due to the loss of a
facilitation of the flexor component as well.
Spontaneous activity . Reports on the effects of agents which increase
5-HT transmission on spinal reflexes describe the appearance of
spontaneous limb activity (e.g. athetoid movements, tremors) (Anden et
al., 1968). Spinalization rules out any contribution of supraspinal
influences to these observed effects. Bedard et al. (1979) recently
reported that 5-HTP produced a marked enhancement of spontaneous EMG
activity in both flexor and extensor muscles of the hindlimb in the
chronically-spinalized rat, and that this increased activity was
12
selectively blocked by cyproheptadine (but not by phenoxybenzamine )
.
Intraperitoneal injection of 5-HT did not mimic this effect, suggesting
a central site of action for 5-HTP. Furthermore, administration of 1-
DOPA or the dopamine agonist apomorphine had no such effect, suggesting
that the EMG activation (which correlated with spontaneous movements)
was specific to 5-HT activation.
The spectrum of behaviors induced by 5-HT agonists in the intact
cat or rat has been referred to as the "5-HT syndrome." This consists
of "forepaw treading", head swaying and bobbing, and splayed hindlimbs
(Sloviter et al., 1978). Another correlate of 5-HT activation is "limb
flicking" seen most clearly in cats. Many of the components of the
5-HT syndrome can be seen in the pontine decerebrate preparation,
suggesting that 5-HT in the lower brainstem and/or spinal cord is
sufficient to mediate this activation (Jacobs and Klemfuss, 1975).
Modulation of sensory transmission ( pain ) . Yaksh and Wilson (1979)
have suggested that spinal 5-HT release in the dorsal horn blocks the
transmission of stimuli that code for pain. Although these studies
were not carried out in spinalized rats, local administration of drugs
to the spinal cord was achieved by infusion through intrathecal
catheters. Using this technique, the authors found that intrathecal
5-HT elevated response thresholds to aversive thermal stimuli, and this
elevation was enhanced by treatment with 5-HT uptake blockers
(fluoxetine, imipramine). Quipazine, but not 5-HTP or tryptamine,
mimicked the effects of 5-HT. Quipazine and 5-HT were blocked with the
5-HT antagonist methyserglde but not with the NE antagonist
13
phenoxybenzamine. Methysergide alone produced hyperalgesia, suggesting
that 5-KT exert a slight, tonic inhibitory influence on pain
transmission (Proudfit and Hammond, 1981).
Spinal 5-HT fibers appear to mediate some of the supraspinal
actions of morphine, as well. Yaksh et al. (1980) found that
behaviorally defined analgesia (an increase in tail flick latency) that
was produced by morphine injected into the periaqueductal grey in the
brainstem was partially blocked by intrathecally administered
methysergide. However, such antagonism was not evident using the hot
plate test, leading Yaksh to suggest that this "supraspinally
organized" pain measure was not affected by descending 5-HT systems.
It should be noted that the tail flick is a spinal reflex, and as such
the effects of intrathecally administered drugs should be evaluated
with caution. The need to evaluate possible contributions of motor
deficits is clear.
Supersensitivity .
Transection . Several studies have provided evidence that reflex
supersensitivity to 5-HT agonists develops following spinal
transection. The 5-HT agonists 5-MeODMT (0.1 - 2.0 mg/kg) and
quipazine (5-20 mg/kg) were shown to produce augmented spinal
reflexes, beginning as soon as 1 - 2 days after transection (Sautter et
al., 1981). Interestingly, enhancement of 5-HT receptor binding
(indicated by an increase in the number of [3h]5-HT binding sites,
without a change in affinity) was seen beginning only a week after
14
transection. That is, functional supersensitivity preceded biochemical
indices of supersensitivity. The authors interpreted this finding to
mean that enhanced responsiveness seen less than a week after
transection was due to alterations in presynaptic mechanisms.
Nozaki and his colleagues have also provided evidence for
functional 5-HT supersensitivity following transection, using the whole
limb flexion reflex. They found that chronic spinal rats (rats
transected for two months or more) showed greater responses to 5-HTP,
LSD, and tryptamine than did acute spinal rats (rats transected for two
days or less)
.
NeurotQx;3,ns. Nygren et al. (1974) have provided functional evidence
for supersensitivity of the hindlimb extensor reflex following
intracisternal administration of 5,6-DHT. They found that 5-MeODMT or
1
-tryptophan + nialimide produced greater responses in neurotoxin
treated rats controls as soon as four days (5-MeODMT) or at a week
( 1-tryptophan)
.
As mentioned previously, 5-HTP induced increases in spontaneous
E^X3 activity in hindlimb flexor and extensor muscles following
transection (Bedard et al., 1979). Interestingly, these increases
showed a progressive augmentation, such that, at 20 days following
transection, a maximal response was achieved. At any given point, the
5-HTP induced activity was reversed by cyproheptadine. That this
progressive increase is attributable to supersensitivity is supported
by the finding that rats treated with 5,6-DHT and, twenty days later,
transected, showed EMG responses to 5-HTP the day following transection
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that were equal in magnitude to those seen twenty days after
transection. Intrathecal depletion of 5-HT with 5,7-DHT has also been
shown to enhance the antinociceptive effects of 5-HT and 5-HT agonists
(Howe and Yaksh, 198I).
Neurophysiology (evoked potentialsK Measures of monosynaptic (short
latency) and polysynaptic (long latency) massed electrical reflex
activity can be obtained by stimulating cut dorsal roots and recording
the response in ventral roots in anesthetized or unanesthetized
(decerebrate/spinal) preparations. Drug-induced changes in the
parameters of the monosynaptic reflex (MSR) indicate direct or indirect
modulation at the level of the motoneuron whereas changes in the
polysynaptic reflex (PSR) suggests that modulation takes place at
multiple sites of action along the interneuronal pathways. Recording
or stimulating from nerve fibers from individual extensor or flexor
muscles or muscle groups provides information that is more specific
than that obtained from ventral or dorsal root fibers.
Monosynaptic reflexes . Studies in spinalized preparations have yielded
results that are, in general, compatable with the excitatory effects of
5-HT activation on reflex behavior and spontaneous activity.
Administration of the 5-HT precursor 5-HTP has been reported to
increase the amplitude and decrease the latency of the MSR in the acute
spinal cat (Taber and Anderson, 1973; Banna and Anderson, 1968). This
facilitation was blocked by cinnaserin, cyproheptadine, methysergide
and LSD (Banna and Anderson, 1968). The antagonist effect of LSD is in
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contrast to its facilitatory effect on flexor reflexes (Nozaki et al,,
1977; Maj et al., 1976).
Tryptamine has been reported to facilitate the MSR in cats, and
this facilitation was blocked by cyproheptadine, but not
phenoxybenzamine (Vaupel and Martin, 1976). Tryptamine was previously
shown to enhance the flexor, but not the extensor, cutaneous reflexes.
Finally, the 5-HT agonist quipazine similarly augments the MSR of the
acute spinal cat, and this increase was blocked by cinnanserin
(Goldstein and Anderson, 1973) but not by metergoline (Goldstein and
Anderson, 1981).
Studies utilizing electrical stimulation of the raphe nuclei in
decerebrate preparations have yielded conflicting results. Electrical
stimulation of the median raphe has been reported to increase the
amplitude of the MSR in the rat (Barasi and Roberts, 1973; 1974). This
effect was potentiated by 1 -tryptophan, whereas treatment with
methysergide, cinnanserin, or LSD blocked the effect. Clineschraidt and
Anderson (1976), on the other hand, reported that raphe stimulation
produced both excitatory and inhibitory effects on the MSR, suggesting
the possible involvement of multiple pathways.
It should be recalled that Commissiong and his colleagues found
that, in the decerebrate preparation, stimulation of 5-HT neurons
produced an inhibition of extensor reflexes, in contrast to the
excitatory effects seen in studies utilizing spinalized preparations.
In the decerebrate preparation, activation of competing spinal and
supraspinal 5-HT pathways may exert opposite modulatory influences on
spinal reflex behavior.
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In an elegant series of studies, Sastry and Sinclair have provided
evidence for 5-HT involvement in the modulation of a number of
inhibitory processes that affect the amplitude of the MSR. Their
studies included analyses of both flexor (posterior biceps,
semitendinosus complex) and extensor (quadriceps) muscle groups. The
majority of the evidence supported a primary role in the modulation of
extensor activity.
Recurreyit inhibition ^ ^he extensor MSR . Activation of an
a
-motoneuron is known to produce a feedback inhibition (via a
collateral synapsing onto inhibitory Renshaw cells) of itself and
adjacent motoneurons. This inhibitory feedback serves the purpose of
distributing activation of motoneurons evenly among the cells
comprising a homonymous motoneuron pool. Recurrent inhibition of an
extensor (quadriceps) MSR was reduced by agents which facilitate 5-HT
transmission (5-HTP, the 5-HT uptake blockers fluoxetine and
imipramine, and pargyline) (Sinclair and Sastry, 1974; Sastry and
Sinclair, 1976). This antagonism was blocked by cyproheptadine.
Furthermore, thoracic block of descending impulse flow (these studies
were carried out in decerebrate cats) blocked the effects of fluoxetine
and imipramine. Since the spinal block alone increased recurrent
inhibition (and this increase was blocked by PCPA pretreatment ) , it was
concluded that the 5-HT descending fibers exerted a tonic inhibitory
influence on extensor recurrent inhibition. It should be noted that
alpha-methyl-para-tyrosine (AMPT, a catecholamine synthesis inhibitor)
produced results similar to those obtained with PCPA, suggesting
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catecholamine involvement as well.
Presynaptic inhibition Qf^ extensor MSR : Imipramine and fluoxetine
blocked presynaptic inhibition of the quadriceps MSR that is elicited
by stimulation of antagonist flexor la afferent fibers ("reciprocal
inhibition") (Sastry and Sinclair, 1977). This blockade was prevented
by cold block of the thoracic cord, or by pretreatment with
cyproheptadine. Either of these treatments alone enhanced presynaptic
inhibition, suggesting that 5-HT exerted a tonic inhibitory influence
on this process. PCPA pretreatment prevented the imipramine reduction
and the cold block enhancement of presynaptic inhibition, supporting a
tonic facilitatory role of descending 5-HT neurons. Again, AMPT
effectively antagonized the effect of imipramine, leading the authors
to conclude that descending 5-HT and NE fibers were "serially arranged"
and both served to antagonize presynaptic inhibition of the extensor
MSR
.
Bulbospinal inhibition of the MSR: Stimulation of the ventromedial
bulbar reticular formation produces an inhibition of the MSR of both
flexors and extensors (Llinas and Terzuolo, 1964). Using antidromic
field potentials from the extensor quadriceps nerve as a measure of
motoneuron activity and field potentials from the afferent nerve as a
measure of presynaptic activity, Sastry and Sinclair (1976) reported
that bulbospinal stimulation produced both postsynaptic inhibition
(reduction of motoneuron field potentials) and presynaptic inhibition.
These effects were antagonized by imipramine (Sastry and Sinclair,
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1976; Sinclair and Sastry, 1974), and the imipramine effect was itself
blocked by cyproheptadine or by prior treatment with PCPA, and not AMPT
(Sastry and Sinclair, 1976).
Studies similar to those described above were carried out on a
flexor (posterior biceps-semitendinosus) MSR as well. In marked
contrast to the results obtained with the extensor, it was found that
altering 5-HT transmission in the spinal cord had little effect on
recurrent inhibition (Sastry and Sinclair, 1976; Sinclair and Sastry,
1974) and presynaptic inhibition (Sastry and Sinclair, 1977) of the
flexor MSR. However, bulbospinal inhibition of the flexor MSR was
antagonized (albeit weakly) by administration of imipramine.
The studies by Sastry and Sinclair illustrate subtle, yet
important influences of the descending 5-HT systems on inhibitory
processes affecting the monosynaptic reflexes. It is difficult to
relate these findings to studies looking at the behavioral concomitants
of spinal 5-HT activation. At this point, they are of importance in
emphasizing that modulation of reflex behavior by descending pathvijays
may be exerted at many different loci within the cord and through a
number of different mechanisms. An excitatory effect on a reflex may
be attributable to direct or indirect activation of motoneurons or
interneurons or to removal of any of a number of inhibitory influences.
These studies further illustrate important differences in the type of
preparation used to study spinal reflexes: the decerebrate preparation
in which the descending 5-HT systems were functionally intact revealed
tonic 5-HT influences that would have gone undetected in the spinal
preparation.
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P0lY9Ynaptj.C HSflsxes. 5-HTP has been found to depress polysynaptic
reflexes (Banna and Anderson, 1968), though the lack of reversibility
by 5-HT antagonists led the authors to conclude that the effect was not
serotonergically-mediated. 5-HTP was also found to depress dorsal root
reflexes. Recently, it has been shown that quipazine, a 5-HT agonist,
also depresses various indices of dorsal root activity (dorsal root
potential, dorsal root discharge, dorsal root reflex) in acute spinal
rats (Goldstein and Anderson, 1981). This effect was gradual in onset
(taking about 30 minutes to occur), and was reversed by metergoline,
but not by cinnanserin. It is interesting to compare this effect with
the effect of quipazine on the MSR: quipazine produced a rapid onset
facilitation which was blocked by cinnaserin but not by metergoline
(Goldstein and Anderson, 1981).
On the other hand, tryptamine has been reported to facilitate
polysynaptic reflexes (Vaupel and Martin, 1976; Bell and Martin, 1974)
in a cyproheptadine-reversible fashion. Even more pronounced effects
were obtained when long latency polysynaptic reflexes (elicited by
preferential stimulation of high threshold, slowly-conducting C-fibers)
were measured. Thus, administration of 1 -tryptophan (Bell et al.,
1976) or tryptamine produced a marked increase in the long-latency PSR
which was blocked by cyproheptadine. In contrast to its antagonist
effect on the MSR, LSD produced a cyproheptadine reversible increase in
polysynaptic reflexes (Bell and Martin, 197^). This effect was
somewhat gradual in onset, and peaked an hour after injection.
Single cell actlvitv . As previously mentioned, electrical stimulation
21
of the median raphe increased the amplitude of the MSR (Barasi and
Roberts, 1973, 1974). Using multibarreled recording/iontophoresis,
these authors showed that raphe stimulation increased the size of the
evoked field potential in the ventral horn. This facilitatory effect
could be mimicked by iontophoretic application of 5-HT onto
motoneurons. Furthermore, the increases in field potentials could be
antagonized by iontophoretic application of cinnanserin or methysergide
onto motoneurons. White and Neuman (1980) similarly found that
iontophoretic application of 5-HT onto motoneurons increased the
excitability of these cells to iontophoretically-applied glutamate, or
to antidromic stimulation from the ventral roots. This increase in
excitability occurred without a direct increase in the firing of the
motoneurons, consistent with a role of 5-HT as a neuromodulator in the
spinal cord. Recently, similar findings have been made with the
putative 5-HT agonist quipazine (Neuman and White, 1982).
Myslinski and Anderson (1978) carried out an elegant series of
experiments investigating the effects of 5-HT precursors (5-HTP and
1-tryptophan) on a- and A-raotoneuron fibers in dissected ventral root
fibers. They found that 1-tryptophan produced increases in both ry- and
X-motoneuron activity. The increased a- motoneuronal activity was not
attributable to activation of the A_ioop, since opening the loop (by
cutting the dorsal root fibers) failed to abolish the a-motoneuron
response. Thus, activation of the stretch reflex was not solely
attributable to increased X-motoneuron discharge.
Furthermore, by recording motor units in peripheral nerve
filaments from both flexor (semitendinosus) and extensor
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(gastrocnemius) muscles, they discovered that cu and X-motoneuron
activation occurred in both types of fibers. These effects were
reversed by cyproheptadine and cinnanserin. These findings are
consistent with the enhancement of EMG activity that occurred in both
flexors and extensors following 5-HTP administration (Barbeau and
Bedard, I98O). Furthermore, they clarify seemingly conflicting reports
that facilitation of flexor and extensor reflexes occurs following
drug-induced increases in 5-HT transmission.
Myslinski and Anderson acknowledged that they could not determine
whether a-motoneuron activation was direct or through interneurons.
However, in view of the findings of White and Neuman (1980), and in
view of the activation of interneurons seen following 5-HTP
administration (Phyllis et al., 1968), it is likely that the latter
mechanism (activation indirectly through interneurons) is operative.
Dorsal horn ; Consistent with behavioral studies suggesting that 5-HT
release in the dorsal horn of the spinal cord produces analgesia,
several studies have shown that electrical stimulation of the raphe
magnus reduces the excitability of dorsal horn interneurons, and this
effect is blocked by 5-HT antagonists (Duggan and Griersmith, 1979;
Fields et al., 1977; Proudfit and Anderson, 197^). Responses of dorsal
horn interneurons to noxious stimuli were more effectively blocked than
was activity in large diameter fibers. Furthermore, iontophoretically
applied 5-HT depressed the firing of neurons activated by noxious
stimuli ("nociceptors" in the substantia gelatinosa), and this effect
was blocked by methysergide (Belcher et al., 1978; Headley, et al..
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1978; Griersmith and Duggan, 1980).
Recently, two populations of spinothalamic neurons have been
identified as having opposite responses (excitation and inhibition) to
5-HT (Jordan et al., 1979). There appeared to be a functional
distinction between these two types of neurons, in that cells excited
by 5-HT received their inputs from "deeply-situated" muscle afferents,
whereas neurons depressed by 5-HT were more responsive to
"exteroceptive" stimuli originating from hair movements, skin
stimulation, and painful plantar stimulation. This report provides
evidence that descending 5-HT neurons may modulate, in opposite ways,
cells in the spinal cord that are responsible for transmitting sensory
information to supraspinal levels.
Supinary
.
There is strong anatomical and neurochemical evidence for the
existence of descending serotonergic fiber systems. Furthermore,
activation of these pathways in the spinal animal facilitates flexor
and extensor spinal reflexes that are elicited by activation of
cutaneous and muscle afferents. However, there is evidence that 5-HT
may exert inhibitory influences on extensor stretch reflexes in non-
spinalized, decerebrate animals, suggesting that multiple 5-HT pathways
may exert opposite effects on the reflex. Facilitation of spinal cord
5-HT activity in spinalized animals can also produce spontaneous
movements in flexors and extensors, and may be partly responsible for
the occurrence of the post-decapitation reflex. Behaviorally-defined
analgesia has been reported to accompany activation of spinal 5-HT
neurons, probably those that terminate in the dorsal horn. Chronic
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destruction of descending 5-HT fibers, either by transection or by use
of specific 5-HT neurotoxins, produces signs of denervation
supersensitivity. Thus, increases in the facilitatory effects of 5-HT
agonists on spinal reflexes and on activity of muscles, as well as
enhanced antinociceptive effects of these drugs, have been found.
Neurophysiological studies provide evidence for many types of
serotonergic modulation on spinal neural activity. Facilitatory
modulation of spinal mono- and polysynaptic reflexes and single cell
activity has been shown. Inhibitory influences have also been
reported, especially in decerebrate animals, suggesting that 5-HT may
exert opposite effects on spinal neurons through multiple (spinal and
supraspinal) sites of action.
Descending Noradrenergic Neurons
Anatomy
. Studies employing a variety of techniques have established
that NE cell bodies in two primary areas of the brainstem (designated
A1 - 3 and A6, according to the terminology of Dahlstrom and Fuxe,
1964) give rise to terminal projections in the dorsal and ventral horns
along the entire length of the spinal cord (Dahlstrom and Fuxe, 1964;
Carlson et al., 1964; Ungerstedt, 1974; Lindvall and Bjorklund, 1974;
Nygren and Olson, 1977; Commissiong et al., 1978; Karoum et al., 1980).
Nearly all of the norepinephrine found in the spinal cord is contained
within descending fibers, since total disappearance of NE occurs within
a week following transection (Anden et al., 1964). The pontine (A6)
cells, located in the locus coeruleus and subcoeruleus, appear to
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provide the major noradrenergic projection to the ventral horn and the
ventral half of the dorsal horn of the spinal cord, whereas the
medullary (A1-3) cell bodies contribute to the dorsal horn and the
sympathetic lateral column (Nygren and Olsen, 1977; Commissiong et al.,
1978; Guyener, 198O; Mason and Fibiger, 1979). Spinal noradrenergic
fibers would thus appear to be anatomically well-suited to exert
modulatory influences over spinal reflexes.
Mhoie limb flexor reflexes . The isomers of amphetamine are known to
promote the release, and block the reuptake of catecholamines (see
Groves and Rebec, 1976). d-Amphetamine has been found to potently
facilitate the flexor reflex elicited by electrical stimulation of the
plantar region of the hindpaw of spinalized rats (Nozaki et al.., 1977;
Nozaki et al., I98O) or spinalized dogs (Martin and Eades, 1967). This
excitation was attributed to action on NE neurons, since it was blocked
by pretreatment with the a-NE antagonist phenoxybenzamine.
Phenoxybenzamine alone was reported to have little or no effect on the
baseline of the flexor reflex (Martin and Eades, 1967; Nozaki et al.,
1980); furthermore, the activation by amphetamine was not blocked by a
5-HT antagonist (cyproheptadine), or by a 6-NE antagonist
(dichloroisoproterenol) (Nozaki et al., 1977; Martin and Eades, 1967).
Finally, 1 -amphetamine has also been found to increase the amplitude of
the toe-pinch elicited flexor reflex (Svensson et al., 1975).
Intravenous administration of the a^-NE agonist methoxamine has
been reported to facilitate the flexor reflex in spinalized rats
(Nozaki et al., 1977, 1980) and dogs (Martin and Eades, 1967). As with
amphetamine, this stimulation appeared to be dependent on stimulation
of a-noradrenergic receptors, since it was blocked by phenoxybenzamine
but not by the 6-NE antagonist dichloroisoproterenol (Martin and Eades,
1967).
The catecholamine precursor 1-DOPA has been shown to facilitate
the flexor reflex evoked by pinching the toes of spinalized rats (Anden
et al., 1970) and this effect was blocked by phenoxybenzamine. The
lack of attenuation by even high doses of the DA antagonist pimozide
(20 - 25 mg/kg) supports the conclusion that the effect of 1-DOPA is
not mediated by increased activity at spinal DA receptors (see,
however, section on DA involvement in spinal reflex behaviors).
Clonidine, a drug purported to have mixed o-agonist properties
(Clough and Hatton, 1981), has been shown to produce a marked, 1-DOPA-
like facilitation of the hindlimb flexor reflex in spinalized rats
(Anden et al., 1970; Anden et al., 1978; Nutt et al., 1980). This
effect has been attributed to the activation of a^-NE receptors, since
it was blocked by the a^-NE antagonists prazosin (Anden et al., 1978)
and phenoxybenzamine (Anden et al., 1970; Anden et al., 1975).
Pretreatment with a2-antagonists yohimbine and piperoxane has been
found to be less efficacious in antagonizing this effect (Anden et al.,
1975).
Individual flexor muscles . Maj and his coworkers have utilized the
tibialis anterior flexor reflex (described in the 5-HT section) to
analyze the contribution of spinal NE neurons to the flexor reflex.
Their findings support the results from the whole limb flexor studies,
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I.e. that a facilitation of spinal noradrenergic activity increases the
flexor reflex. Thus, clonidine and d-amphetamine both produced an
increase in amplitude of the flexor reflex, and these effects were
blocked by pretreatment with phenoxybenzamine (Maj et al., 1976).
Haloperidol was later reported to block the increase produced by
clonidine (Maj et al., 1978). The authors attributed this blockade to
noradrenergic blocking properties of haloperidol, since they found that
the DA antagonist pimozide did not attenuate the clonidine induced
effect. Blockade of 5-HT receptors with several drugs (cyproheptadine,
metergoline ) failed to influence the effect of clonidine or amphetamine
on the flexor reflex (Maj et al., 1976). Finally, clonidine has been
reported to produce a phenoxybenzamine-reversible activation of the
psoas flexor reflex (Austin et al., 1976), consistent with the results
obtained with the tibialis anterior and whole limb flexor reflexes.
Stretch reflexes . The stretch reflex is absent in spinalized rats,
though (as mentioned previously) it can be restored by the
administration of 1-DOPA (Anden et al., 1964). Because this effect was
reversed by pretreatment with phenoxybenzamine, it was concluded that
1-DOPA increased the availability of NE which then activated
noradrenergic receptors in the ventral horn. Furthermore, it was
concluded (on the basis of electrophysiological measurements) that NE
increased the discharge in static X-motoneurons, thereby restoring
resting tension in the intrafusal fibers (and restoring the sensitivity
of the muscle spindle afferent fibers to stretch). Recently,
Coraraissiong has challenged this hypothesis, suggesting rather that the
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effects of 1-DOPA are attributable to activation of DA receptors.
Commissiong found that 1-DOPA increased the stretch reflex in the
decerebrate rat, and that this increase was blocked completely by 0.2
mg/kg pimozide (Commissiong and Sedgwick, 1979). (See section on DA
for other data.) Furthermore, Commissiong (1981) concluded that NE
release in the spinal cord of the decerebrate rat was, in fact,
inhibitory to the stretch reflex. He cited several experiments to
support this conclusion: (1) DOPS (an analog of 1-DOPA which is
directly metabolized to NE) produced only a depression of the stretch
reflex; and (2) administration of cyclobenzaprine, a muscle relaxant,
increased discharge of the locus coeruleus (and increased turnover of
NE in the ventral horn) and concomitantly depressed the stretch reflex
in the decerebrate rat. However, Barnes et al., (1980) found just the
opposite results with cyclobenzaprine (that is, the drug depressed
locus coeruleus firing while at the same time depressing spinal
monosynaptic responses). Finally, Maxwell (1975) suggested that the
increase in extensor tone following intercollicular decerebration (so-
called " X-rigidity") might be due to enhanced noradrenergic activation,
since drugs which blocked noradrenergic transmission ameliorated the
condition. Clearly, more direct evidence needs to be gathered before
definite conclusions regarding the role of NE in modulating tonic and
phasic stretch reflexes can be made. Nonetheless, it is an intriguing
possiblity that multiple noradrenergic pathways may exert both
excitatory and inhibitory influences on stretch reflexes through
actions at spinal and supraspinal levels, respectively. This "dual-
action" could provide a parallel to that suggested for serotonergic
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systems (see 5-HT section).
P(?st-decapntat1on reflex. The integrity of the post decapitation
kicking response (PDR — described earlier) is highly dependent upon
noradrenergic transmission (Roberts et al., 1978, 1979; Pappas et al.,
1979). Thus, attenuation of the response occurs following pretreatment
with AMPT, the a,-NE antagonist prazosin, chlorpromazine, or U1il-62i| (a
DA-6-hydroxylase inhibitor) (Pappas et al., 1979). Lesions of the
locus coeruleus (either electrolytic or 6-OHDA) also reduce the PDR.
Trifluoperazine, a DA receptor blocker, did not affect the response;
nor did lesions of the ascending fibers of the NE pathways (Roberts et
al., 1978, 1979).
Spinal stepping . Elegant studies by Grillner and his colleagues have
shown that the "pattern generator" for producing the alternation of
flexors and extensors that comprises locomotion is found within the
spinal cord. In fact, each limb appears to have its own "pattern
generator" which (while capable of working independently) work in
concert to produce locomotor movements. This conclusion has been
derived from studies in which spinalized animals are placed on a moving
treadmill. When all afferent input to the spinal cord is cut, either
stimulation of the cut dorsal root, or intravenous injection of 1-DOPA,
can produce "treadmill stepping" movements. L-DOPA activates the
"stepping generator" by increasing the availability of NE in the spinal
cord, since its effects are blocked by pretreatment with the NE
antagonist phenoxybenzamine. Electrophysiological studies have
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indicated that the locomotor movements are produced by a co-activation
of a- and X
-motoneurons. Thus, descending neurons of the locus
coeruleus have been implicated in being a "command center" for
activating a spinal locomotion generator.
Modulation ol_ ^ensorv transmission ( pain ). Descending NE neurons, like
5-HT, appear to modulate the transmission of sensory information in the
dorsal horn of the spinal cord. Electrical stimulation of the nucleus
reticularis gigantocellularis produces behaviorally defined analgesia
(Mohrland and Gebhart, 1980) (Yaksh et al., 1981) that is blocked by
intrathecal administration of the a-adrenergic antagonist phentolamine,
but not the 5-HT antagonist methysergide (Yaksh et al., 1981).
Furthermore, a variety of NE agonists produce analgesia when injected
intrathecally (Reddy and Yaksh, 1980; Reddy et al., 1980; Yaksh and
Wilson, 1979). These effects were antagonized selectively by a^-NE
receptor blockers. Finally, analgesia produced by morphine injected
into the periaqueductal grey is attenuated by intrathecal phentolamine,
suggesting that descending NE fibers play an important role as a "link"
between the brainstem and spinal cord in the modulation of pain
signals.
Supersensitivitv . Nygren et al. (1976) found that acutely-spinalized
rats depleted of spinal NE by prior pretreatment with the catecholamine
neurotoxin 6-hydroxydopamine (6-OHDA) showed enhanced FR responses to
clonidine. The authors suggested that the potentiated clonidine effect
was indicative of the development of underlying noradrenergic receptor
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supersensitivity. Recently, Howe and Yaksh (1982) demonstrated that
depletion of spinal NE with intrathecal 6-OHDA produced an enhanced
antinociceptive effect of NE and NE agonists, again interpeted to be an
indicant of denervation supersensitivity.
Neurophysiology .
MonosynaptiQ reflexes. In spinalized cats, administration of the
-adrenergic agonist methoxamine has been found to increase the
amplitude of the MSR in a dose-dependent manner (Vaupel and Martin,
1976), and this effect was blocked by phenoxybenzamine. Additionally,
1-DOPA was found to increase the amplitude of the MSR (Baker and
Anderson, 1970), and this effect was reversed by phenoxybenzamine and
chlorpromazine. It should be recalled that Commissiong and his
colleagues found that increasing noradrenergic transmission in
decerebrated rats produced an inhibition of the extensor stretch
reflex, in contrast to the excitatory effects seen in the transected
preparation. Recently, it has been reported that electrical
stimulation of the locus coeruleus markedly increased the amplitude of
the lumbar MSR in decerebrate cats (Strahlendorf et al., 1980). This
augmentation was reversed by phenoxybenzamine and chlorpromazine, but
not haloperidol, supporting the conclusion that the stimulation-induced
increase was mediated by noradrenergic neurons. This study does nei.
support Commissiong 's contention that noradrenergic neurons inhibit the
stretch reflexes. (In addition, it was found that locus coeruleus
stimulation produced a facilitation of both extensor and flexor MSRs,
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suggesting that descending NE neurons exert general facilitatory
influences on monosynaptic reflex activity).
PolYsynaptic refle:^es: 1-DOPA has been shown to depress the dorsal
root reflex and the PSR elicited by sural nerve stimulation (Baker and
Anderson, 1970). The inhibitory effect of DOPA on the dorsal root
reflex was shown to be blocked by phenoxybenzamine or chl orpromazine.
SilPile qelj. actj,Yity. Lundberg and his colleagues published a series
of papers describing the effects of 1-DOPA on interneuronal activity in
the spinal cord. These interneurons, identifiable only in spinal
animals and only after injection of 1-DOPA, showed complex patterns of
responses to peripheral activation that made them well-suited to
participate in a "spinal generator" for the production of alternate
extensions-flexions needed for basic movement (Jankowska et al., 1967;
Kostyuk and Vasilenko, 1979).
Following spinal transection, there is a reduction in static
A-efferent activity, and increase in dynamic A-efferent activity. 1-
DOPA increases static and decreases dynamic activity, leading to the
conclusion that a NE pathway "sets the balance" between static and
dynamic fusimotor activities (Grillner, 1969). Furthermore, this
mechanism has been found to underlie the production of spinal stepping
by 1-DOPA in cats (see Grillner, 1975). Similar electrophysiological
changes have been found in rats following d-amphetamine administration
(Sorenson et al., 1978).
Until recently, studies employing iontophoretic application of NE
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onto spinal motoneurons found weak, inconsistent effects (usually
inhibitory) (Engberg and Ryall, 1966). However, recently it has been
suggested that ME might not act as a classical transmitter in the
spinal cord, but rather as a neuromodulator. Thus, iontophoretic
application of NE onto motoneurons of the lumbar cord increases the
excitatory effects of afferent input to those cells (White and Neuman,
I98O). This increase occurred without the direct activation of
motoneuronal firing, and was blocked by pretreatment with
phenoxybenzamine
.
Interestingly, Hodge et al (1981) recently reported that
stimulation of the locus coeruleus produced inhibitory responses on
dorsal horn neurons (lamina 4 and 5, areas purported to be involved in
the relay of pain), whereas cells in the ventral horn (lamina 6) were
actually activated. Thus, opposite effects of stimulation of the same
descending system neurochemical system can exert opposite effects on
neurons in the dorsal is. ventral horn. These responses may help
explain contradictory functional findings reported previously.
Summary . There are several descending noradrenergic pathways that
could affect spinal reflex activity, most notably the pathway that
arises from the nucleus locus coeruleus/subcoeruleus complex.
Increasing spinal noradrenergic activity increases polysynaptic flexor
reflexes and restores monosynaptic stretch reflexes in spinalized
animals. However, there is some evidence that supraspinal
noradrenergic neurons may exert opposite (inhibitory) influences on
spinal reflexes. Spinal noradrenergic activity is critical for the
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occurrence of the PDR. Furthermore, spinal noradrenergic activation
produces "stepping movements" and results in behaviorally-defined
analgesia,
Neurophysiological studies indicate that increasing noradrenergic
transmission in the spinal cord facilitates mono- and polysynaptic
reflexes, and activates the neural circuitry that produces stepping
movements. Single unit and iontophoretic studies indicate that NE acts
as a facilitatory neuromodulator in the ventral horn. However, cells
in the dorsal horn that transmit nociceptive information to the brain
have been found to be inhibited by increased spinal noradrenergic
transmission.
Descending Dopaminergic Neurons
Anatomv . Until recently, it has been thought that the small quantities
of DA measured in the spinal cord existed only as precursor to NE.
However, with the development of refined techniques for tracing
monoamine pathways, it has become evident that discrete descending
dopaminergic pathways do in fact exist. Interestingly, the highest
concentrations of DA are found in the dorsal horn. High levels are
also found in the zona intermedia, suggesting an interaction with
preganglionic sympathetic neurons (Commissiong, 1979). Discrete
hypothalamo-spinal (Blessing and Chalmers, 1979) and nigro-spinal (cf.
Commissiong, 1979) pathways have recently been identified.
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Mo(jUl^tj,Qp q£_ SDinal reflexes .
Mh2i£ limb new reflexes. Administration of the DA agonist
apomorphine (0.5 mg/kg) has been reported to produce an increase in the
hindlimb flexor reflex in rats (Nygren and Olsen, 1976). However, this
effect was only seen in rats pretreated with 6-OHDA; thus, action of
the drug on supersensitive DA receptors might be necessary to "bring
out" an excitatory effect of the drug. Commissiong and Neff (1979)
have suggested that spinal DA receptor activation may mediate the
facilitatory effects of 1-DOPA on the flexor reflex, on the basis of
neurochemical evidence that 1-DOPA increases the synthesis of primarily
DA. However, Anden et al. (1970) concluded that 1-DOPA was not working
through DA receptors, since even extremely high doses of the DA
antagonist pimozide (20 - 25 mg/kg) failed to block the effects of 1-
DOPA on the hindlimb flexor reflex.
Single muscle flexor reflex . Maj and his coworkers have reported that
spinal dopaminergic neurons play an insignificant role in the
modulation of flexor reflexes, in that doses as high as 5 mg/kg
(intravenously) failed to affect the amplitude of the tibialis anterior
reflex (Maj et al., 1978).
Stretch reflexes . The catecholamine precursor 1-DOPA can restore the
stretch reflex which is otherwise absent in the spinalized preparation.
This effect has been attributed to the stimulation of NE receptors,
since it is blocked by phenoxybenzamine. However, Commissiong (197^)
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suggested that DA might be involved, since the effect of 1-DOPA on the
stretch reflex in an extensor muscle was blocked by a low (.3 mg/kg)
dose of pimozide. Furthermore, apomorphine (0.5 gm/kg) was found to
produce a short (10-15 minute) activation of the stretch reflex
(Commissiong and Sedgwick, 1979).
Modulation M sensory information ( pain ) . Although there is currently
no evidence that DA release in the spinal cord is involved in
antinociception, there is an indication that a descending DA pathway
from the substantia nigra might indirectly affect spinal pain
transmission. Barnes et al. (1979) found that nigral stimulation
produced a marked inhibition of lamina V cells that were normally
excited by noxious stimuli. Similar effects were elicited by
stimulation of the periaqueductal grey and the dorsal raphe. Since the
nigral stimulation has been reported to be effective in decerebrates,
and since it is blocked by dopamine antagonists (Barnes et al., 1979)
i
the effect appeared to be attributable to a descending pathway.
Furthermore, since the inhibition of lamina V activity by stimulation
of all three sites (nigra, raphe, and periaqueductal grey) were blocked
by 5-HT antagonists, it was tentatively concluded that the descending
DA pathway (and the pathway from the periaqueductal grey) converged on
the raphe and influenced spinal transmission through the raphe-spinal
projection.
Supersensitlvitv . Gentleman et al. (1981) recently reported that a DA-
activated adenylate cyclase (reversible by haloperidol) exists in the
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spinal cord. This cyclase can also be activated by apomorphine.
Furthermore, following transection of the spinal cord, a 5-10 fold
increase in the sensitivity to DA was found, indicative of the
development of denervation supersensitivity.
Modulation of other behaviors .
Spontaneous activitv. Commissiong and Sedgwick (1979) reported that
apomorphine (0.5 mg/kg) produced a marked increase in spontaneous EMG
activity, which they attributed to increased X
-motoneuron activation.
Since this data was gathered in the decerebrate preparation, it is
possible that the drug indirectly affected motoneuronal activity by
acting on supraspinal receptors.
Neurophysiology .
Monosynaptic reflexes . Electrical stimulation of the substantia nigra
has been reported to facilitate the MSR in both flexor and extensor
muscles (York, 1972). This facilitation appeared to be DA-mediated,
since it was reversed by haloperidol. Furthermore, descending systems
were involved, since the facilitation was still present in decerebrate
rats.
Langer et al. (1979) recently reported that haloperidol
administration (in doses up to 0.3 mg/kg, i.p.) reduced the MSR of both
flexor and extensor a-motoneurons (though flexors were more sensitive).
They suggested that neuroleptic induced catalepsy which is classically
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associated with blockade of forebrain DA receptors, might involve a
decrease in the efficacy of la muscle afferents to elicit activation of
a-motoneurons.
Single .sell aQtiVAtv. Barasi and Roberts (1977) investigated the
effects of iontophoretically applied DA to a-motoneurons in the ventral
horn of the lumbar cord of rats. DA was found to increase the
excitability of motoneurons (indicated by an increase in the field
potentials from antidromically activated cells). This facilitation was
blocked by the DA receptor blocker oufiupenthixol, which by itself did
not influence the excitability of the cells, a-fllupenthixol did not
increase the excitability produced by 5-HT, though unexplicably , it
enhanced the excitability induced by NE.
Summary . There is now evidence for the existence of discrete
descending dopaminergic neurons, though the primary projection areas
may be the dorsal horn. Activation of DA neurons in the spinalized
preparation does not affect cutaneous flexor reflexes, though it has
been reported to facilitate extensor stretch reflexes, as well as
producing tonic, spontaneous muscle activity. Descending DA neurons
from the substantia nigra may indirectly exert antinociceptive effects
by influencing raphe-spinal stimulation. Biochemical evidence for DA
supersensitivity in the spinal cord after transection has been found,
though there are no reports of a functional correlate to this
supersensitivity. Neurophysiological evidence suggests that a nigral-
spinal descending projection can exert facilitatory effects on flexor
39
and extensor reflexes. Furthermore, there is some evidence at the
single cell level for facilitatory effects on motoneurons.
Spinal GABAergiG Neurons
Anatomy
.
GABA and its synthesizing enzyme GAD are localized in the
greatest concentration in the dorsal horn or spinal cord, particularly
the substantia gelatinosa (Barber and McLaughlin, 1980; Barber et al.,
1978).
I
I
Modulation of spinal reflexes .
j
I
I
Whole llfflb flexor reflexes . Administration of the GABA antagonist I
I
I
bicuculline has been reported to produce a slight enhancement of the
]
hindlimb flexor reflex (Nutt et al., 1980), suggesting that spinal GABA
|
neurons exert a slight tonic inhibition on the reflex. Muscimol and
THIP, putative GABA agonists (Johnston, 1978), and vinyl GABA, a GABA-
transaminase inhibitor that elevated spinal GABA levels by ^00%, all
had little effect on the whole limb flexor reflex in spinalized rats.
On the other hand diazepam, a benzodiazepine, produced a marked, dose-
dependent depressant effect on the reflex (Nutt et al., 1980).
Single muscle flexor reflexes . In contrast to the slight excitatory
effect on whole limb flexion, bicuculline has been reported to have no
effect on the flexor reflex measured by an EMG in the biceps femoris
muscle (MacDonald and Pearson, 1979). (This experiment was carried out
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in non-spinalized rats, a condition which might account for the
different results.) On the other hand, the GABA antagonist picrotoxin
(2 rag/kg) was found to facilitate the tibialis anterior flexor reflex
in acutely spinalized rats (Sypniewska, 1979; Georgiev and Rawlow,
1978). This finding supports the conclusion that spinal GABA neurons
are tonically inhibitory to the flexor reflex. Baclofen, a putative
GABA agonist (Johnston, 1978) was found to depress the reflex
(Sypniewska, 1979); however, neither picrotoxin nor bicuculline
antagonized this depression, suggesting that the drug was not working
through a GABA mechanism. Interestingly, baclofen appeared to act more
j
like a 5-HT antagonist, since it attenuated the effects of quipazine
and LSD on the flexor reflex (Sypniewska, 1979).
I
Stretch reflexes . Diazepam has a marked muscle relaxant effect which i
has been attributed to its ability to depress A-motoneuron discharge.
This effect is achieved with very little effect on a-motoneuron
activity (Takano and Student, 1978). Consistent with its inability to
silence ot-motoneuron activity, diazepam has been shown to have little
effect on mono- or poly-synaptic reflexes, even at high doses (e.g. 10
mg/kg) (Pole et al., 1974). In fact, this preferential blockade may
explain why diazepam is effective as a muscle relaxant in some
preparations but not others (Andersen and Raines, 1972; Maxwell, 1975).
Spinal Glvcinergic Neurons
Anatomy . The existence of glycine neurons in the spinal cord.
particularly the ventral horn, is well documented (cf. Johnston, 1978).
The transmitter is organized in a rostral
-caudal gradient in the
central nervous system, with the greatest concentration of neurons and
receptors found in the spinal cord. Glycine has been shown to mediate
post-synaptic inhibition in both the spinal cord and brainstem (Curtis
et al., 1968; Werman et al., 1968; Belcher et al., 1976).
MQ(ju3.at3,on ol spinal reflexes .
Fl9X9r refles^e?. Like GABA, spinal glycine neurons appear to exert a
tonic inhibitory influence on the flexor reflex, since administration
of the glycine antagoist strychnine (Curtis et al., 1968) increased the
amplitude of the flexor reflex in spinal rats (MacDonald and Pearson,
1979).
Stretch reflexes . Intravenous administration of glycine into
decerebrate cats has been found to produce a marked, long-lasting
depression of the stretch reflex of the extensor triceps surae muscle
(Takano and Neumann, 1972). Strychnine reversibility was not tested.
Summary ( GABA and glycine ) . There is clear evidence for the presence
of spinal GABA and glycine neurons. Studies using putative GABA and
glycine antagonists have shown that these drugs produce facilitatory
effects on cutaneous flexor reflexes, probably through a blockade of
tonic spinal inhibition. GABA agonists (there is not a good glycine
agonist currently available) produced little or no effects on the
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flexor reflexes, suggesting that the tonic inhibition is near maximal.
Benzodiazepines, most notably diazepam, appear to selectively block
a-motoneuron discharge, without directly acting on X
-motoneurons.
Other Neurochemical Systems
Cho3.3,nergi G neurons. Recent work using receptor binding techniques has
revealed sizeable concentrations of muscarinic cholinergic receptors
throughout the grey matter of the spinal cord, the number of which are
unaffected by transection (Kayaalp and Neff, 1980; although see
Charlton et al., 1981 for report that receptor number is diminished
following transection). However, very little work has been devoted to
the systematic evaluation of spinal cholinergic systems to the control
of reflex behavior. Martin and Eades (1967) studied the effects of
cholinergic agonists and antagonists on the flexor reflex in
chronically-spinalized dogs and found that physostigmine, a
cholinesterase inhibitor, increased the amplitude of the reflex. The
muscarinic cholinergic antagonist atropine blocked this increase,
leading the authors to conclude that muscarinic receptor activation
facilitated the flexor reflex.
Peptides : substance 2 and thyrotropin releasing hormone . Substance P
and thyrotropin releasing hormone (TRH) have been shown to be co-
localized in descending 5-HT terminals (Gilbert et al., 1982),
particularly those terminals innervating the ventral and lateral grey
matter of the spinal cord. These peptides do not appear to be found in
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descending CA terminals, since intraventricular injection of
6-hydroxydopainine failed to affect spinal localization. On the other
hand, intraventricular injection of 5,7-DHT resulted in a virtual
disappearance of spinal 5-HT, TRH, and substance P; two other peptides,
met-enkephalin and somatostatin, were unchanged. Interestingly, there
was no depletion of substance P in the brain following 5,7-DHT
treatment, suggesting that spinal 5-HT neurons may be unique in their
peptide content. Gilbert et al. commented that 5-HT, TRH, and
substance P-labelled fibers could be seen most strikingly localized
around somatic motor neurons.
Krivoy et al. (1980) have recently provided electrophysiological
evidence that substance P functions as a neuromodulatory transmitter in
the spinal cord. They found that substance P applied iontophoretically
to motoneurons of the cat spinal cord produced an increased sensitivity
of the cells (at high currents) to afferent barrages from stimulation
of the dorsal root.
Substance P has been suggested to have a role in the dorsal horn
as a transmitter for sensory (pain) information, perhaps at the level
of the primary afferent. lontophoretic application of substance P
produced a strong excitation of responses in laminae I - III to noxious
stimuli (while depressing or having no effect on responses of neurons
to light touch or pressure) (Randic and Miltic, 1977). Furthermore,
intraspinal injection produced scratching, indicative of hyperalgesia
(Piercey et al. , 1981 )
.
^eurpctiemlcal Modulation ^ jy^e Acoustin Startle Reflex
The evidence presented thus far illustrates that a number of
neurochemical systems that either descend from the brain
(norepinephrine, serotonin, dopamine) or that are intrinsic to the
spinal cord itself (GABA, glycine, acetylcholine) can modulate spinal
reflex activity. One could now pose the question, do these spinal
I
transmitter systems have relevance to behaviors whose neural circuitry
'
are of supraspinal origin? Recent work in the laboratory of Dr.
Michael Davis has indicated that spinal neurochemical systems play an
important role in the modulation of the acoustic startle response. The
I
I
acoustic startle reflex is a short-latency activation of the skeletal '
musculature that follows the presentation of an intense auditory
\
I
stimulus. The neural circuitry underlying the startle reflex involves
\
a relatively simple ear-brainstem-spinal cord-muscle reflex arc.
Stimulation, lesion, and anatomical studies indicate that the
transmission of the startle-eliciting neural impulses proceeds from the
auditory nerve to the ventral cochlear nucleus to the nuclei of the
lateral lemoriscus, to the nucleus reticularis pontis caudalis; and
then down the reticulo-spinal tract where (either directly or through
interneurons) activation of a-motoneurons (and subsequent muscle
contraction) takes place.
In order to localize the site of action of a systemically-
administered drug to the spinal cord, investigators studying spinal
reflexes routinely use a spinal transection to eliminate the influence
of supraspinal structures. Obviously, when studying a behavior such as
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the acoustic startle reflex which requires the integrity of the
brainstem-spinal cord connection, such a procedure cannot be used.
However, Tony Yaksh has developed a simple technique for infusing drugs
directly into the subarachnoid space of the lumbar spinal cord in
unanesthetized, behaving animals (see Yaksh and Rudy, 1976). Using the
"intrathecal technique", Davis and coworkers have found that
intrathecal infusion of a variety of drugs that affect spinal
neurochemical transmission can alter the amplitude of the acoustic
startle response.
Serotonin. Using this technique, it has been shown that intrathecal
infusion of drugs that increase 5-HT transmission in the spinal cord
(5-HT + pargyline, 5-MeODMT, PCA) all produce increases in acoustic
startle. Furthermore, these effects are blocked by pretreatment with
5-HT antagonists (Davis et al., 1980; Davis, 1980; Davis et al., 1979).
|
Thus, on a qualitative level, the startle reflex would appear to '
respond similarly to treatments which enhance 5-HT transmission in the
spinal cord as do the whole limb and single muscle flexor reflexes (see
previous section).
In marked contrast to the facilitatory effects of intrathecal
administration of 5-HT agonists on the startle reflex, intraventricular
infusion of these drugs produces an opposite (inhibitory) effect on
this behavior (Davis et al., 1980). The opposite effects of spinal vs.
supraspinal infusions of these drugs has been interpreted as
representing the activation of spinal excitatory and supraspinal
inhibitory 5-HT systems. The ultimate behavioral outcome of systemic
i{6
injection would thus depend upon the net balance between these
anatomically distinct modulatory systems.
Dppapine
.
Systemic adminstration of the DA agonist apomorphine
produces a potent increase in acoustic startle (Davis and Aghajanian,
1976). However, this effect does not appear to be mediated in the
spinal cord, since intrathecal administration of apomorphine, over a
wide range of doses, failed to affect startle amplitude (Davis and
Astrachan, unpublished observations).
QABA. Recent work indicates that the acoustic startle reflex is
modulated by spinal GABA neurons. Intrathecal administration of the
GABA antagonist picrotoxin has been shown to produce a dose-dependent
increase in startle amplitude, in doses that are subconvulsive
(Gallager et al., submitted). These data suggest that GABA neurons
tonically inhibit the startle reflex pathway, perhaps through direct
postsynaptic inhibition of a-motoneurons involved in the startle reflex
pathway.
Glycine . Systemic administration of strychnine has been found to
produce a potent facilitation of acoustic startle in subconvulsive
doses (Kehne et al., 1981). This effect appears to be mediated at
least in part by action of strychnine at the level of the spinal cord,
since intrathecal administration of the drug produced a dose-dependent
increase in startle. These data suggest that glycine neurons normally
exert a tonic inhibitory influence on the acoustic startle pathway.
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perhaps through direct, post-synaptic Inhibition of the a_motoneurons
involved in the response. This conclusion is supported by preliminary
data which indicates that direct, intrathecal administration of glycine
produces a slight depression of startle (unpublished data).
Norepinephrine. A variety of evidence supports the conclusion that
increasing NE transmission in the spinal cord produces an increase in
acoustic startle. Intrathecal administration of NE increased startle
(Astrachan and Davis, 1981). This effect was blocked by the
a^-adrenergic antagonist WB-4101. The a^-adrenergic agonist
phenylephrine also increased startle when given intrathecally . The
effect of phenylephrine has been shown to be blocked by WB-4101, but
not by the 6-adrenergic antagonist propanolol, the DA antagonist
haloperidol, or the 5-HT antagonist cyproheptadine (Astrachan and
Davis, 1980; Davis and Astrachan, 1981). Intrathecal administration of
d-amphetamine also increased startle in a dose-related fashion, and
this effect was blocked selectively by a ^-adrenergic antagonists.
Clonidine, a drug that has been reported to have mixed a-agonist
properties (e.g. Clough and Hatton, 1978), produced a marked depressant
effect on the acoustic startle reflex. This depression occurs either
when the drug was given systemically or intrathecally (Davis et al .
,
1977; Davis and Astrachan, 1981). The depressant effects of clonidine
were reversed by the a^-adrenergic antagonist yohimbine (Davis and
Astrachan, 1981) suggesting that clonidine depresses the startle reflex
by stimulating ag-adrenergic receptors. However, the depressant effect
of clonidine does not appear to be simply due to its ability to
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suppress firing of locus coeruleus neurons, since bilateral
electrolytic lesions of this locus failed to abolish the depressant
effect (Davis et al., 1977). However, recent evidence indicates that
the adjacent "subcoeruleus" gives rise to descending noradrenergic
fibers (Guyenet, I98O). Therefore, the depressant effect of clonidine
might be due, at least in part, to a depression of descending
noradrenergic neurons from the subcoeruleus.
Spinal Neurochemi cal Modulation : A Comparison of Flexor and Startle
Reflexes
The studies just described using intrathecal drug administration
have implicated a number of spinal neurochemical systems in the
modulation of the acoustic startle response. This should hardly be
surprising, since the startle reflex involves a widespread contraction
of the flexor musculature (Landis and Hunt, 1939), and data cited
earlier in this chapter showed the prominent effects of pharmacological
agents on spinal reflexes. In fact, if the pharmacology of the startle
reflex is compared with that of the flexor reflex (FR) (see Table 1), a
number of striking parallels are seen. For example, agents which
facilitate 5-HT transmission (5-HT itself; the putative 5-HT agonists
LSD, 5-MeODMT; the 5-HT releasing agent PCA) increase the flexor and
startle reflexes. An enhancement of spinal DA transmission (with the
DA agonist apomorphine) fails to alter either reflex behavior.
Furthermore, blockade of GABA transmission (with the GABA antagonist
picrotoxin) or glycine transmission (with the antagonist strychnine)
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enhances both startle and flexor reflexes. (Since these drugs are
apt^goqists
,
an excitatory effect on the behavior implies that spinal
GABA and glycine neurons normally exert a tonic inhibitory effect on
the two reflexes.) Finally, agents which facilitate noradrenergic
transmission, such as the releasing agent d-amphetamine, and the
a ^-adrenergic agonists methoxaraine and phenylephrine, produce
excitatory effects on the startle and/or flexor reflexes. It should be
emphasized that, in the flexor studies, the animals are spinalized,
thereby ruling out supraspinal sites of action of the systematically
adminisstered drugs. Furthermore, the intrathecal infusion of drugs in
intact rats insures direct administration at the level of the lumbar
cord. In conclusion, the striking correspondence between the
excitatory effects of these drugs on the FR and the startle reflex
suggests that common spinal sites of action are involved.
However, there is a notable exception to this generalization.
Administration of the a -adrenergic agonist clonidine has been reported
to facilitate the FR when given systemically (Anden et al
. ,
1970, 1975,
1978; Austin et al., 1976; Nutt et al., 1980). On the other hand, the
drug markedly depresses acoustic startle when given either systemically
(Davis et al., 1977) or intrathecally (Davis and Astrachan, 1981).
Clonidine has been reported to have 'mixed' a-adrenergic agonist
properties; that is, it is thought to act on both -adrenergic and
a2-adrenergic receptors (Clough and Hatton, 1981; Kobinger and Pichler,
1981). The clonidine induced vasopressor effect has been attributed to
its peripheral a^-adrenergic agonist properties (Kobinger, 1978), while
centrally, clonidine acts as a potent ct^-agonist to depress the firing
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of neurons in the locus coeruleus (Cedarbaum and Aghajanian, 1977;
Svensson et al., 1975). The a^- and a2-agonist actions of the drug are
blocked by specific antagonists, such as prazosin (a^-adrenergic
antagonist, Cavero and Roach, 1978) and piperoxane (a2-adrenergic,
Cedarbaum and Aghajanian, 1977; Svensson et al., 1975).
The clonidine-induced facilitation of the FR has been reported to
be more readily blocked by than a2-antagonists (Anden et al., 1970,
1975, 1978; Austin et al., 1976; Nutt et al., 1980), whereas the
clonidine-induced depression of the startle reflex has been shown to be
blocked by the aj-adrenergic antagonist piperoxane, but not by the
a^-adrenergic antagonist phentolamine (Davis et al., 1977). Given the
otherwise consistent pharmacology of the FR and the startle reflex, it
is not readily apparent why clonidine should act more like an
a2-adrenergic agonist to depress startle while acting like an
-adrenergic agonist to facilitate the FR.
In fact, clonidine has been reported to exert ot^-adrenergically
mediated depressant effects on a number of different behaviors, such as
locomotor activity (Clineschmidt et al., I98O; Delini-Stula et al.,
1979; Skolnick et al., 1978; Strombora and Svensson, 1980; Reinstein and
Isaacson, 1977; Tilson et al., 1977), self-stimulation (Franklin and
Herberg, 1977), conditioned avoidance (Laverty and Taylor, 1969), food-
reinforced operant responding (Tilson et al., 1977), pain-elicited
aggression (Laverty and Taylor, 1969), as well as exerting sedative
effects (Kosman, 1975; Pettinger, 1975; Laverty and Taylor, 1977).
Thus, across a wide range of behaviors, clonidine exerts depressant
effects that are consistent with the effect seen on acoustic startle.
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but not with the effect seen on the FR.
In conclusion, the FR is clearly different from other behavioral
paradigms in revealing an
.adrenergic excitatory effect of clonidine.
The reason for this discrepancy is not readily apparent, though it
should be noted that the FR is routinely measured in spinally-
transected ( 'spinalized' ) animals, whereas other behavioral paradigms
involve the use of intact animals. Spinalization per se might result
in conditions which would produce a shift in the properties of
clonidine from an a^- to an -adrenergic agonist. If this were the
case, then it might be predicted that clonidine would show an effect on
the FR in "intact" (i.e. no n-spinalized) rats that was more consistent
with the effects of the drug on other behaviors. That is, clonidine
might be expected to depress the FR in the intact rat through a
stimulation of ct^-adrenergic receptors.
Consistent with this prediction, the following studies showed that
clonidine produced an ot^-adrenergically mediated depression of the FR
in intact rats, in contrast to its ot^_adrenergic excitatory effect in
spinalized rats. Furthermore, it appears that this inhibitory effect
is due to the activation of supraspinal ot^-adrenergic receptors,
whereas the excitatory effects of clondine in the spinal rat are due to
the activation of spinal ct^
-adrenergic receptors. In the intact rat,
the inhibitory effect of clonidine predominates over the excitatory
effect, whereas, in the spinalized rat, the supraspinal a^-adrenergic
system is disengaged, allowing the ot^ .excitatory effect to be
expressed.
CHAPTER 2
EFFECTS OF THE a-ADRENERGIC AGONIST CLONIDINE ON THE FLEXOR REFLEX IN
INTACT AND SPINALIZED RATS
gypQrlm^nt 1: EffeQtg SiL clonldlne Hie IE in Intact^ spinallv-
tr9nge(;t;,9<j ratg. The purpose of this experiment was to determine the
effects of a range of doses of IP clonidine on the FR in spinalized and
intact (non-spinalized) rats.
3ul?.l9Ct3. Male, albino rats (350-450 g) were used in this and all
subsequent experiments. The weight range was 350-450 g unless
otherwise specified. Rats were housed in group cages (4-5 per cage)
in a colony room with a reverse light-dark cycle (12h - 12h). Food and
water were available ^ libitum .
Spinal transection . Previous studies have demonstrated excitatory
effects of clonidine on the FR in rats that have undergone low cervical
(C8), high thoracic (T1 - T3), mid-thoracic (T4 - T5), or low thoracic
(T10 - T12) spinal transections (Anden et al., 1970; Austin et al.,
1976; Nozalci et al., 1980; Nozaki et al., 1977; Nutt et al., 1980;
Nygren and Olson, 1977). Pilot studies similarly indicated that the
precise level of transection was not critical for observing this
effect. For consistency, all transections performed in the following
studies were carried out at T1-T2 (first and second thoracic
vertebrae). This high thoracic level was chosen for several reasons:
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(1) The greater distance from the site of the FR circuitry (the lumbar
spinal cord) was thought to minimize non-specific damage to the reflex
pathway that might otherwise occur with lower transections. (2) It was
easier to obtain surgical access to the spinal cord through the
vertebral column at this level, since the column is more "flexible"
than at higher levels (allowing for normal movement). (3) This level
is marked by a prominent landmark, a vertically-projecting spinous
process that allowed rapid and precise localization of the site of
transection.
For the 'spinalized' group, rats were maintained under halothane
anesthesia throughout the duration of the operation (10 - 15 minutes).
i
Following initial anesthetization, a rat was placed in a Kopf
;
stereotaxic instrument and a 6 cm incision was made through the skin on '
the back. Overlying thoracic muscles were displaced away from the
j
I
midline with surgical retractors, and the ligaments and tissues
i
I
I
surrounding the column at the site of the transection were cut away. A
laminectomy was then performed using a pair of bone rongeurs. By
removing both the dorsal and lateral components of the vertebrae, the
spinal cord could be easily visualized. A curved suture needle held
firmly with a pair of hemostats was then inserted underneath the cord,
and the cord was gently lifted. A pair of surgical microscissors was
used to completely sever the spinal cord. After bleeding had been
controlled, the site of the transection was covered with Gelfoam and
gauze to control further bleeding and the incision was sutured shut.
The final step involved inserting a metal ring (made from a 19 gauge
hypodermic needle) through the skin behind the base of the Achilles'
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tendon. This ring served as the point of attachment of the hindlimb to
the force transducer.
Following completion of the operation, the rat was removed from
the stereotaxic instrument and was placed in a cage under a tensor lamp
until the time of testing. Despite the apparent severe nature of the
operation, mortality was rarely encountered. Rats recovered from the
anesthesia within 5-10 minutes, and, despite the complete paralysis
of their hindquarters, would often move themselves about the cage with
their forelimbs.
For the 'intact' group, rats were anesthetized with halothane and
placed in the stereotaxic instrument for 10 minutes and then allowed
two hours for recovery.
Testing-
Apparatus . The apparatus used to quantify the flexor reflex was
modified from descriptions from the literature (Austin et al., 1976;
MacDonald and Pearson, 1979; Anden et al., 1978; Nygren and Olson,
1976), as were the various stimulation parameters. Prior to testing,
rats were placed in a Bollman restraining cage that had been modified
so that the hindlimbs of the rats hung down through two holes cut in
the bottom of the cage. The left leg was taped to a support so that it
remained stationary. The right leg was connected to a Grass force
transducer by means of a metal ring inserted through the skin behind
the base of the Achilles' tendon. The output of the force transducer
was amplified through a Grass Model 7P1 A Low-Level D.C. pre-ampllfier
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and displayed on a multi-channel polygraph chart recorder. The
sensitivity of the pre-amplifier was maintained at 2 mv/cm. The
stimulus for eliciting the hindlimb flexor reflex was a 2 msec square
wave pulse from a Grass S88 Stimultor fed through a Grass SIU5 Stimulus
Isolation Unit. The stimulus was delivered through two insect pins
(the ends of which were separated by 3 mm) implanted subcutaneously in
the sole of the right hindpaw. The electrode was taped securely to the
hindpaw to assure that it remained in a stationary position throughout
the period of testing. The amplitude of the flexor reflex was
quantified by measuring the length (in mm) of the response traced on
the polygraph paper.
Procedure
. Both • spinal ized' (n=27) and 'intact' (n=12) groups were
tested under similar conditions 2 hours following termination of the
anesthesia. Five minutes after being placed in the test apparatus, 30
eliciting stimuli were presented at a 20 second interstimulus interval
(i.e. a 10 minute 'baseline' period). Three different stimulus
intensities (15v, 30v, and 60v), presented in a quasi-randomized order,
were used to evoke a range of flexor responses. The parameters were
derived from previous reports (Austin et al., 1976; MacDonald and
Pearson, 1979). Following the 10 minute 'baseline' period, rats were
injected IP with saline, and 15 minutes later, were presented with a
second group of 30 stimuli (20 second interstimulus interval; 'saline'
period). At the end of the 'saline' period, rats were injected IP with
either saline or a single dose of clonidine. Fifteen minutes after
this second injection, a third test was carried out ('clonidine'
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period). Thereafter, the rats were removed from the test apparatus.
Each rat was tested only once.
^^^" J'^^ ^ ai9CUg9j.on. Fig. 1 shows the effects of saline injections
alone (right panels) or saline injection followed by 0.5 mg/kg
clonidine (left panels) in spinalized rats (upper panels) or intact
rats (lower panels). In the groups that received saline injections
only, the amplitude of the FR remained relatively stable across the
three test periods. In the rats that received saline followed by
clonidine, a marked depression occurred in the intact group following
clonidine administration, whereas an excitation occurred in the
spinalized group.
As seen in Fig. 2, clonidine produced a dose-dependent depression
of the FR in 'intact' rats, whereas it produced a dose-dependent
excitation in 'spinalized' rats. Each bar represents the change scores
(mean response amplitude after clonidine adminstration minus the mean
response amplitude for the test period prior to clonidine
administration) at each dose of clonidine or following saline
administration.
It is important to recognize the dramatic depression of baseline
level of responding seen in the 'spinalized' group relative to the
'intact' group (see Figs. 1,2). Without exception, transected rats
showed weak responses to the same intensity stimuli that produced
vigorous responses in the non-spinalized rats. Since the change scores
used to generate Fig. 3 described drug-induced changes in the FR
relative to the predrug baseline, it might be argued that, in one
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sense, the clonidine 'depression' of the FR is artificial. That is,
the post-clonidine scores in 'intact' rats, though lower than the
baseline scores, might be similar to the levels achieved in the
'spinalized' rats following clonidine injection (and thus revealing an
underlying excitatory effect). Fig. 3 shows the absolute post-
clonidine scores (averaged across the stimulus intensities) following
the injection of the different doses of clonidine. Clearly, the
absolute levels of responding are lower in the 'intact' rats relative
to the 'spinalized' at the 0.5 and 2.0 mg/kg doses. Therefore, in both
absolute and relative terms, clonidine depressed the FR in 'intact'
rats and increased the FR in 'spinalized' rats.
A one-factor analysis of variance (ANOVA) of the change scores in
the 'spinalized' group revealed a significant overall drug effect (F =
11.8; df = 4,10; p<.001) that was linearly related to the doses tested
(0.125, 0.25, 0.5, 1.0, and 2.0 mg/kg) (F^^^ = 42.4; df = 1,10;
p<.001). A similar analysis of the change scores for the 'intact'
group showed a significant overall drug effect (F = 6.70; df = 4,16;
p<.005) that was lineraly related to the doses used (0.007, 0.03,
0.125, 0.5, and 2.0 mg/kg) (F^^^ = 25.3; df = 1,16; p<.001). Cubic and
quadratic trend analyses were not significant for either 'intact' or
'spinalized' groups.
The dose range for the excitatory effects of clonidine on the FR
is similar to that reported by other investigators (Nutt et al., 1980;
Anden et al.
,
1978; Austin et al., 1976). In the 'spinalized' group, a
0.125 mg/kg dose of clonidine produced a threshold FR activation. Two
of the three rats tested at this dose showed no increases at any of the
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three stimulus intensities used, and the third showed only a very
slight augmentation at the highest intensity. In contrast, the
depressant effects in the 'intact' rats were evident at a lower (0.03
mg/kg) dose.
Experiment 2.: Pioeroxane and prazosin antagonism clonidine's
effQQts m iiie FR in intact
.aM spinalized rats . The purpose of the
second experiment v/as to determine whether the observed effects of
clonidine on the FR were attributable to an activation of a ^.adrenergic
and/or a^-adrenergic receptors. Prazosin and piperoxane have been
shown to be relatively specific a ^-adrenergic and a2-adrenergic
antagonists, respectively, in electrophysiological, biochemical, and
behavioral studies (Menkes et al., I98I ; Cavero and Roach, I98O; Langer
et al., 1980; Greengrass and Bremner, 1979; Hornung et al., 1979; Davis
et al., 1977; Cedarbaum and Aghajanian, 1977; Cedarbaum and Aghajanian,
1976; Langer, 1974).
Methods . 'Spinalized' (n=9) and 'intact' (n=9) groups of rats were
prepared as described previously. Rats were pretreated with either 10
nig/kg piperoxane, 1.0 mg/kg prazosin, or vehicle (distilled water) one-
half hour before being placed into the test apparatus. Rats were
tested using a different procedure from that used in the prior
experiment (the procedure to be described will be employed in all
subsequent experiments unless otherwise designated). Five minutes
after the rats were secured in the apparatus, five eliciting stimuli
(30 V, 2 msec duration) were presented at a one minute interstimulus
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interval. This constituted the pre-drug 'baseline'. Immediately after
the fifth stimulus, the rats were injected with either 0.5 mg/kg
clonidine or vehicle (IP). The dose of clonidine was chosen since it
produced near-maximal effects on the FR (as seen in Fig. 2). The rats
were presented with an additional 30 stimuli, also at a 1 minute
inter stimulus interval (the 'post-injection' scores). Animals were
tested only once.
Results .and discussion. The bottom three panels of Fig. H show the
effects of pretreatment with either vehicle (left panels), 10.0 mg/kg
piperoxane (middle panels), or 1.0 rag/kg prazosin (right panels) on the
FR in 'intact' rats before and after treatment with either 0.5 mg/kg
clonidine (closed circles) or saline vehicle (open circles). Each
point represents the mean amplitude FR across 5 stimulus presentations.
In the vehicle and prazosin pretreated groups, clonidine treatment
produced a marked depression of the FR, relative to both the pre-
injection baselines, and to the post-vehicle treatment scores. There
was no significant effect of the three pretreatments on post-vehicle
treatment scores. In the piperoxane pretreated group, the clonidine
depression appeared to be blunted (though not completely blocked).
Fig. 5 shows the mean change scores (30 minutes post-injection minus 5
minutes pre-injection) following vehicle or clonidine treatment for the
three pretreatment groups. This graph shows that the piperoxane
pretreatment blunted the depressant effect of clonidine, while prazosin
was without effect.
An overall ANOVA with 'pretreatment' (vehicle, piperoxane, and
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prazosin) and 'treatment' (vehicle, clonidine) as factors revealed a
non-significant pretreatment effect (F = 2.73; df = 2,12 n.s.), a
significant treatment effect (F = 88.2; df = 1,12 p<.001) and a
significant pretreatment x treatment interaction (F = 6,96; df = 2,12;
p<.01). A subsequent two-factor ANOVA with 'treatment' (vehicle,
clonidine) and 'pretreatment' (vehicle, piperoxane) as factors revealed
a significant treatment effect (F = 33.3; df = 1,8; p<.001), a non-
significant pretreatment effect (F = 3.62, df = 1,8; .05<p<.1), and a
significant treatment x pretreatment interaction (F = 8.5; df = 1,8;
p<.025). The significant interaction effects supports the conclusion
that piperoxane blunted the depressant effect of clonidine. A similar
analysis for the prazosin pretreated group revealed only a significant
treatment effect (F = 82.8; df r 1,12; p<.001), supporting the
conclusion that prazosin had no effect on the clonidine depression of
the FR.
The top three panels of Fig. 4 show the effects of pretreatment
with vehicle (left panel), 1.0 mg/kg prazosin (right panel), or 10
mg/kg piperoxane (middle panel) on the FR in 'spinalized' rats before
and after treatment with vehicle or 0.5 mg/kg clonidine. In contrast
to its lack of effect on clonidine inhibition in 'intact' rats,
prazosin pretreatment completely prevented the excitatory effect of
clonidine on the FR. Piperoxane appeared to partially block the effect
of clonidine. These observations are further illustrated in Fig. 5, in
which the mean change scores are expressed. The three pretreatments
provided similar effects on the baseline, with response levels
declining to near zero across the test session.
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A two-factor ANOVA with ' pretreatment • (vehicle, prazosin) and
'treatment' (vehicle, clonidine) as factors revealed significant
pretreatment (F = 21.0; df = 1,8; p<.001) and treatment (F = 31.0; df =
1,8; p<.001) effects and a significant pretreatment x treatment
interaction effect (F = 23.0; df = 1,8; p<.001). A similar analysis
for the piperoxane pretreated groups revealed significant pretreatment
(F = 6.0; df = 1,8; p<.05) and treatment (F = 60.1; df = 1,8; p<.001)
effects, and a significant pretreatment x treatment interaction (F =
5.54; df = 1,8; p<.05). The significant interactions in both
pretreatment groups support the conclusion that both piperoxane and
prazosin antagonized the clonidine response, though from the graphs it
is apparent that the prazosin blockade was by far the greater effect.
The results from the first two experiments suggest that clonidine
depresses the FR in intact rats, at least in part, through an
a2-adrenergic mechanism, whereas it increases the FR in spinalized rats
through an activation of
-adrenergic receptors. Because the
spinalization procedure effectively eliminates the effect of direct
supraspinal neural influences on the FR circuitry, it is reasonable to
conclude that the excitatory effects of clonidine are attributable to
an activation of spinal
-adrenergic receptors. This conclusion is
consistent with anatomical data showing the presence of noradrenergic
nerve terminals in the spinal cord, the cell bodies of which originate
in the pons (Nygren and Olsen, 1977; Commissiong, 1980; Commissiong et
al., 1978a, b; Lindvall and Bjorklund, 1974). However, the first two
experiments do not address the localization within the central nervous
system of the a^-adrenergic mediated inhibitory effects of clonidine.
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One approach to determining where a drug acts within the CNS to
produce a given effect is to use local drug infusions into the
cerebrospinal fluid at the level of the forebrain (intraventricular
administration), or at the level of the spinal cord (intrathecal
administration). However, with highly lipophilic compounds (such as
clonidine), these techniques must be used with caution, since, despite
the local administration, the drug might gain rapid access to other
sites of action (Marwaha et al., 1982).'' Therefore, in the next
experiment, the lipophobic ot^-adrenergic agonist oxymetazoline was
administered directly into the spinal subarachnoid space (intrathecal
administration) or into the lateral ventricle (intraventricular
administration).
There is a strong evidence that clonidine depresses unit activity of
single cells in the locus coeruleus via stimulation of a2-adrenergic
"autoreceptors" located directly on the cell bodies (Cedarbaum and
Aghajanian, 1976). Thus, a series of electrophysiological studies
were carried out using the firing of single units in the locus
coeruleus as a marker for supraspinal actions of clonidine (Marwaha
et al., in prep.). Clonidine produced a rapid, a2-adrenergic
antagonist reversible depression of locus coeruleus neurons when the
drug was administered intravenously, intrathecally or
intraventricularly. Furthermore, the depression seen following
intrathecal administration was still present in spinally-transected
rats, ruling out the contribution of a 'feedback loop' from the
spinal cord to the locus coeruleus. Finally, intraventricular, but
not intrathecal or intravenous administration of the lipophobic
a
-agonist oxymetazoline produced an a2~^^^"®'^®^Sically mediated
depression of locus coeruleus firing. Taken together, these findings
suggested that intrathecal administration of clonidine, but not
oxymetazoline, could gain rapid access to supraspinal sites.
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sm the FR ia intact rats .
Methods .
Catheterization. Rats were implanted with intrathecal or
intraventricular catheters using procedures described in previous
studies (Kehne et al., 1981). For intraventricular implants, a
26-gauge needle was inserted into a 4 cm length of PE-20 tubing and the
tip of the needle was rounded off. Under halothane anesthesia, a burr
hole was drilled through the skull 1.2 mm lateral from the intersection
of bregma and the longitudinal suture. The PE-tubing was then lowered
stereotaxically until the top just entered the brain. A 30-cm length
of tubing filled with sterile saline was attached to the catheter and
held in a vertical position, and the tip lowered into the brain until
the fluid in the tubing flowed freely. At this point, the needle was
judged to have entered the lateral ventricle. The catheter v;as then
secured at this point with dental cement, which adhered to skull
screws. The 26-gauge needle was then removed, and the rats were
allowed to recover 3-4 days before testing.
For intrathecal implants, rats were anesthetized under halothane
and placed in a Kopf stereotaxic instrument. The cisterna magna was
exposed and the overlying membrane punctured. A 8.5-cm length of PE-10
polyethylene tubing fused to a 3-cm length of PE-20 tubing was inserted
into the cistern and gently 'snaked' down over the spinal cord to
terminate in the lumbar enlargment as described by Yaksh and Rudy
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(1976). The PE-20 portion of the catheter was filled with sterile
saline, and the rats were allowed to recover 3-5 days before testing.
ISSting. On the day of testing, rats were placed in the test
apparatus, and a 5 minute pre-infusion baseline was taken, after which
the rats were infused with either 10 ul of vehicle, or a range of doses
of oxyraetazoline (intrathecal doses: 12.5 ug, 50 ug; intraventricular
doses: 3.1 ug, 12.5 ug, 50 ug). (These doses were chosen on the basis
of pilot studies.) Animals were then presented with an additional 30
stimuli (i.e. 30 minutes of testing) and then discarded.
R^sylts aM discussion. Fig. 6 shows the mean scores (30 minutes post
infusion minus 5 minutes pre-infusion) for the intraventricular (left
panel) and intrathecal (right panel) administration of oxymetazoline.
Intrathecally-infused oxymetazoline did not differ from vehicle in its
effects on the FR. However, intraventricular infusion of the drug
produced a marked, dose-dependent depression of the reflex. For the
intraventricular group, a one-way ANOVA with 'dose' as a factor
revealed a significant overall depression of the FR (F = 10.2; df =
3,9; p<.005) that was linearly related to the dose used (F^^^ = 29.5;
df = 1,9; p<.001). The overall F for the intrathecal condition was not
significant (F = .18).
Experiment H: Pioeroxane antagonism S2L oxvmetazoline ' s $ffegt im the
FR . If the depressant effect of intraventricular oxymetazoline on the
FR is attributable to a stimulation of a^-adrenergic receptors, then
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this depression should be reversed bv an n, ^^v, • .l a oy ag-adrenergic antagonist. The
purpose of this experiment was to investigate the effect of systemic
piperoxane (which was shown to antagonize the effect of clonidine in
intact rats) on the oxymetazoline-induced depression of the FR.
Methods. Rats were implanted with intraventricular catheters as
described before. On the day of testing, rats were injected with
either piperoxane (10 mg/kg) or vehicle (IP) and one-half hour later
placed in the test apparatus. A 5 minute baseline was taken, after
which either 10 ul vehicle or 3.25 ug oxymetazoline (in 10 ul vehicle)
was infused, followed by a 30 minute test session.
Results and discussion. Table 2 shows the mean change scores (30
minutes post oxymetazoline minus 5 minutes pre-injection) for the four
test groups. Pretreatment with piperoxane blocked the depressant
effect of this low dose of oxymetazoline. A two-factor ANOVA with
'pretreatment' (vehicle, piperoxane) and 'treatment' (oxymetazoline,
vehicle) as factors revealed a significant treatment effect (F = 6.06;
df = 1,8; p<.05), a non-significant pretreatment effect (F = .53), and
a significant pretreatment x treatment interaction (F = 20.0; df = 1,8;
p<.005). The significant interaction supports the conclusion that
piperoxane pretreatment blocked the effect of intraventricular
oxymetazoline on the FR.
It should be noted that this dose of intraventricular
oxymetazoline is just threshold for producing a depression of the FR
(from previous experiment). Preliminary data suggest that higher
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intraventricular oxymetazoline doses may be more resistant to blockade
by systemic piperoxane pretreatment. Taken together with the data from
the last experiment, these results nevertheless support the notion that
a stimulation of supraspinal a^-adrenergic receptors produces a
depression of the FR in rats. Since the depressant effect of IP
clonidine was also attenuated by piperoxane, these data indicate that
the depressant effects of clonidine on the FR are, at least in part,
attributable to a stimulation of supraspinal a2-adrenergic receptors.
One might argue that the data presented thus far support a
"defacilitation" hypothesis. That is, in the intact rat activation of
supraspinal a^-adrenergic receptors (such as those on locus coeruleus
neurons) by clonidine would decrease impulse flow in noradrenergic
neurons and therefore reduce the normal, tonic facilitation of the FR
circuitry in the spinal cord. (Alternatively, clonidine might act by
disinhibiting an inhibitory spinal interneuron, allowing it to now
inhibit transmission in the FR circuit.) Consistent with both of these
mechanisms, spinal transection per se produces a profound depression of
the reflex, as if a tonic facilitatory influence had been removed.
Furthermore, the inhibitory effects of clonidine in the intact rat were
evident at lower doses than those at which the excitatory effects
became evident in the spinalized rat. In fact, the doses expected to
affect presynaptic a2-adrenergic receptors would be lower than those
required to affect post-synaptic receptors (Cedarbaum and Aghajanian,
1976, 1977). However, there are two pieces of data that are
inconsistent with this schema. First, pretreatment with the
a^-adrenergic antagonist prazosin alone failed to produce a profound
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'transection-like' defacilitation of the FR. Second, even at higher
doses, an excitatory effect of clonidine was not seen in the intact
rat. (Recall that the absolute levels of response amplitude following
clonidine administration were lower in the intact than in the spinal
rats.) Clearly, there is some condition in the intact rat that
prevents the a^-adrenergic effect of clonidine from being expressed.
One possibility is that spinal transection induces a rapid
increase in
-adrenergic sensitivity in the spinal cord. That is,
abrupt cessation of impulse flow in descending noradrenergic neurons
could produce "denervation supersensitivity", resulting in clonidine 's
having an
-adrenergic facilitatory effect on the FR. Another
possible explanation is that spinal transection removes an a2-mediated
supraspinal inhibitory system that, in the intact rat, prevents or
overrides the ct^
.adrenergic spinal excitatory effect. In the intact
rat, the a^-mediated inhibition would predominate over the
-excitation, leading to a net inhibitory effect. Spinalization would
prevent the a2-adrenergic effect from influencing spinal activity and
thus "unmask" a ^-mediated excitation. The purpose of the next series
of experiments was to evaluate the relative merits of the
"supersensitivity" "unmasking" hypotheses.
Experiment 5.'- Effects of clonidine on the FR different times
following spinalization . There is reason to believe that rapid changes
in
-adrenergic sensitivity may take place following transection-
induced denervation of spinal ot^ .adrenergic receptors. Using H-
Prazosln binding, Corr et al. (1981) have reported that ischemia can
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produce a rapid (within 30 minutes) increase in a^_adrenergic receptor
number (without a change in affinity) in myocardium. Since ischemia
can also produce an increase in the electrophysiological responsiveness
of myocardium to a^-adrenergic agonists (see Corr et al., I98I), these
data indicated a rapid development of supersensitivity of peripheral
-adrenergic receptors.
The progressive development of supersensitivity following
transection might be reflected by a progressive increase in the
facilitatory effect of clonidine on the FR. The purpose of this
experiment was to determine the magnitude of the clonidine response at
various times following spinal transection.
Meth<?<;^g. Four groups of rats (n=3 in each group) were transected as
previously described, and were then tested either immediately, 1/2, 2,
or 6 hours following transection for their responses to 0.5 mg/kg
clonidine (IP). The testing procedure was the same as that used in the
antagonism experiment (Expt. 2). Briefly, 5 minutes after being placed
in the cages, a 5 minute baseline was taken (5 stimuli, 30 v intensity,
1 minute interstimulus interval). At the end of the pre-injection
baseline, 0.5 mg/kg clonidine was injected and an additional 30 stimuli
(30 minutes of testing) given.
Results and discussion . Fig. 7 shows the effects of 0.5 mg/kg
clonidine at various times after transection. Each point represents
the mean change scores (last 20 minutes of testing minus pre-injection
baseline). This figure shows a progressive increase in the effect of
clonidine, with a maximal effect occurring 2 hours following
transection. When tested immediately following transection, there was
no sign of clonidine-induced activation.
A one-factor ANOVA showed a significant overall time effect (F =
13.6; df = 3,12; p<.001) that was linearly related to the time after
transection (F^.^
= 25.5; df = 1,12; p<.001). There was also a
significant quadratic trend (F^^^^ = 7.9; df = 1,12; p<.025),
consistent with the slight downward turn in the curve at the last
point.
The finding that, immediately following transection, no excitatory
effect of clonidine was apparent is inconsistent with the notion that
the spinalization "unmasks" an a ^-adrenergic effect that is normally
held in check by supraspinal ot^-adrenergic activaton. The progressive
increase that culminated at 2 hours following transection is consistent
with the idea that a progressive (yet, nonetheless rapid) change in
receptor sensitivity is occurring.
Experiment ^H-orazosin and ^ clonidine receptor binding in
spinalized vs . intact rats . Receptor binding techniques have been used
to evaluate biochemical correlates of receptor supersensitivity in
denervated neural tissues. An increase in the number of a ^-adrenergic
receptors has been found to correlate highly with increased
responsiveness to a^-adrenergic agonists in peripheral and central
systems (cf. Schwartz et al., 1978). If an increase in a ^-adrenergic
receptor sensitivity following transection is responsible for the
emergence of clonidine 's excitatory effect in the transected
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preparation, then an increase in the number of a ^-adrenergic receptor
sites might be seen at the time following transection that corresponds
to the point of maximal clonidine facilitation.
IMliods. Two groups of rats were prepared. One group ('transected',
n=10) was transected under halothane, using the procedure previously
described. The other group ('intact', n=10) received exposure to the
halothane anesthesia for an equivalent amount of time. Two hours
following termination of anesthesia, rats were sacrificed and their
lumbar spinal cords were dissected out and frozen at -70°C. One day
later, these tissues were analyzed for ^H-prazosin and ^H-clonidine
binding using a Scatchard analysis as described below.
Receptor Binding Assavs . A combined ^H-prazosin/^H-clonidine assay,
modified from previously reported procedures (Hornung et al., 1979),
was carried out to estimate dissociation constants (K^) and receptor
densities (B^^^) in crude membrane homogenates of lumbar spinal cords
of treatment and control groups. At specified times following spinal
transection or sham treatment, rats were sacrificed and their lumbar
cords (180 - 230 mg) were rapidly dissected out, weighed, and frozen on
dry ice and stored at -70°C until assay. Binding assays were carried
out 1-2 days following sacrifice. Binding parameters were not altered
by storage for at least 3 weeks at -70°C.
At the time of assay, lumbar cords were pooled for each treatment
condition (7 - 10 rats for each group) and homogenized (using a
Brinkman Polytron, setting 8 for 15 seconds) in ice-cold 50 mM Tris HC1
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buffer (pH 7.4) in a 1:40 weight to volume (w/v) ratio. The resulting
homogenate was centrifuged 42,000 x g for 10 minutes, resuspended in
Tris buffer and centrifuged two additional times. The washed membrane
pellets were resuspended in cold 1:10 (w/v) 50 mM Tris HC1 buffer (pH
7.4), Half of this homogenate was removed and stored on ice for use in
the H-clonidine assay (see below). The other half was further diluted
in Tris buffer (pH 8.0) to a final 1:40 (w/v) concentration. Aliquots
(0.8 ml) of this homogenate were incubated in ascorbic acid iO,^%) in
the presence of varying concentrations of ^H-prazosin (0.05 to 1.0 nM;
Amer sham-Searle; specific activity 20.2 Ci/raMole) and 0.5 M Tris buffer
(pH 8.0) to a 1 ml total volume. Non-specific binding was assessed by
the addition of 10 uM WB-4101 (Ward-Blenkinsop Ltd.). Quadruplicate
samples and duplicate non-specific binding values were obtained for
each concentration of ^H-prazosin. Incubations were carried out at
room temperature for 30 minutes within which time steady state
conditions were achieved. (^H-clonidine assay): Aliquots (0.2 ml) of
the homogenate were assayed for ^H-clonidine binding in the presence of
varying concentrations of ^H-clonidine (0.2 - 5.0 mMole) (Mew England
Nuclear; specific activity 23.8 Ci/raMole) in 0.50 M Tris HC1 buffer (pH
7.4) to a 10 ml total volume. Non-specific binding was assessed by the
addition of 10 uM oxymetazoline. Quadruplicate samples and duplicate
non-specific binding values were obtained for each concentration of ^H-
clonidine. Incubations were carried out at room temperature for 20
minutes, at which time steady state conditions were achieved.
(Filtering): Following the end of the incubation period, samples were
rapidly filtered through GF/B filters (Whatham, C, U.K.) under low
vacuum. The filters were washed with three, 6 ml aliquots of ice-cold
50 mM Tris bufer (pH 7.4) and placed in a liquid scintillation counter.
Results of the Scatchard analysis are reported as specific prazosin (or
clonidine) binding per mg protein, (estimated for each homogenate by
the method of Lowry, et al. (1951)) representing total binding minus
binding in the presence of 10 uM WB-ni01 (^H-prazosin assay) or 10 uM
oxymetazoline (^H-clonidine assay). Scatchard plots of binding of
various concentrations of ^H-prazosin (or ^H-clcnidine ) were derived.
Plotted lines, calculated by least squares regression, were used to
estimate K^^ and B^^^^.
Results and discussion. The Scatchard plot of ^H-prazosin binding to
rat lumbar spinal cord membranes for the 'spinalized' (closed circles)
and 'control' groups is shown in Fig. 8. B/F is the ratio of specific
bound ^H-prazosin to free ^H-prazosin. The negative inverse of the
slope of each curve gives an estimate of the equilibrium dissociation
constant (K^ at 25°C) and the intersection with the abscissa gives an
estimate of the total number of binding sites (B ). The calculated
values were: qogtrol; = i.09 nM; Bj^^^^ = 61.6 fraol/mg protein;
gpinalAzed; =
.92 nM; B^^^^^ = 65.8 fmol/mg protein. Thus, relative
to controls, there was a 15? decrease in K^^ in the transected group of
a 7% increase in the B Figure 9 shows the Scatchard plot for ^H-
clonidine binding in the lumbar spinal cord. Linear regression
revealed the following: control ; = 3.33 nM; Bj^^^^ = 309.3 fmol/mg
protein, transected : = 3.85 nM; B„^^ = 281.4 fmol/mg protein.
Thus, relative to controls, an increase in K^^ (15.6$) and a decrease in
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\ax was found.
It should be noted that a previous assay (in which 3H-prazosin
binding Scatchard analysis alone was carried out), revealed the
following results:
.^^ntroi: K^^ = 2.22 nM; B,,^ = 256 fmol/mg protein;
transected
; = 2.56 nM; B^^^ = 178.7 fmol/mg protein. Thus,
relative to controls, there was a decrease in K^^ (1555) and a marked
increase in B (38?). However, the reported values for control B
max
and were 2-3 times higher than those found in other studies in which
H-prazosin binding was studied in the lumbar spinal cord (Astrachan,
Davis, and Gallager, submitted). In these studies, a relatively high
ligand concentration (5 nM) was included. Previous prazosin binding
studies have reported more than one site apparent at high ligand
concentrations (Horning et al., 1979). Thus the high and B
probably reflect the combination of both high and low affinity
components of prazosin. Later studies used only relatively low (0.05
to 1 nM) concentrations of prazosin; Scatchard analysis of these data
indicated single population of high affinity binding sites.
Although all the functional experiments reported in this research
were carried out on rats that had received high thoracic (T^-Tg)
transections, facilitatory effects of clonidine on the FR have been
similarly reported at mid- and low-thoracic levels (Anden et al., 1970;
Austin et al.
,
1976; Nozaki et al., 1980; Nozaki et al., 1977). Pilot
work confirmed that clonidine still facilitated the FR in low-thoracic
transected rats C^io-Tii). To determine if similar changes in
a ^-adrenergic receptor sites were seen in low- thoracic transected
animals, ^H-prazosin binding was carried out in rats transected at
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T-iQ-T^^). Scatchard analysis of these data is presented in Fig. 10.
Calculated values were: ^ojc^: =
.51 ^m; B^^^ = 39-3 fmol/mg
protein; irans^s^:
. .4^, ^. 3^^^ = 43.9 fmol/mg protein. Again,
relative to controls, a decrease in K (13.7^) and an increase in B
" max
(11.7?) was seen.
Thus, across the three experiments done, there was a consistent
increase in the number of ^H-prazosin labelled binding sites in the
lumbar spinal cords of transected rats relative to controls. However,
the magnitude of the increases were variable, and if the data from the
original experiment is excluded (in which the control values were
unexpectedly high), the increases were 7% - 15?.
Using another behavioral paradigm, the acoustic startle reflex, a
correlation between the increse in the number of
-adrenergic receptor
sites following specific lesions of spinal noradrenergic neurons with
6-hydroxydopamine and behavioral activation following administration of
intrathecal phenylephrine, has been found (Astrachan, Davis, and
Gallager, in press). The present findings indiate that there are
consistent (though perhaps variable in magnitude) increases in
OLj -adrenergic receptor density following transection.
In addition, in the one experiment carried out, there appeared to
be a decrease in the number of ^H-clonidine labelled 0'2-adrenergic
receptor sites in the lumbar spinal cord. If clonidine was exerting
its depressant behavior effect by acting on a2-adrenergic receptors in
the spinal cord, then one would argue that its increased efficacy as a
-adrenergic agonist might be due to a decrease in its a2-adrenergic
receptor-mediated inhibitory properties. However, since intrathecal
administration of o^-adrenergic agonist oxymetazoline was not effective
in depressing the FR (Expt. 3), this explanation seems unlikely.
Exp$rj.ment 1: Effects iqtrathecg phenylephrine ^ iiie M in intact
^ sp;Lnal 3,ged rats. If
-adrenergic supersensitivity occurs within
two hours following transection, then a drug that has predominantly
-adrenergic agonist properties should show a greater facilitatory
effect on the FR in spinalized rats compared to intact rats. The
purpose of this experiment was to compare the effects of the
-adrenergic agonist phenylephrine on the FR in intact xs. spinalized
rats.
MethQd?. Since phenylephrine is lipophobic, the drug was administered
intrathecally to assure its delivery across the blood-brain barrier
into the spinal subarachnoid space. Rats were implanted with
intrathecal catheters as described before. On the day of testing the
baselines of 12 rats ('intact' group) were measured and then they were
infused with either vehicle, 25, 50, or 100 ug phenylephrine dissolved
in 10 ul vehicle. Following 30 minutes of testing, the rats were
sacrificed and their catheters examined for patency. A second group of
12 intrathecally-implanted rats ('spinalized' group) were spinally
transected, with care being taken not to damage the intrathecal
catheters in the process of severing the cord. (Subsequent
examinations of the catheters following sacrifice revealed no damaged
catheters.) Two hours following transection, rats were tested
identically to the 'intact' group for their response to intrathecal
e or phenylephrine. All rats were tested only
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Resulfca and discussion
. Fig. 11 shows the mean change scores (30
minutes post-injection minus 5 minutes pre-injection) for the FR in the
intact (open circles) and spinalized (closed circles) groups following
injection of vehicle, 25, 50, or 100 ug phenylephrine. Inspection of
the curves would seem to indicate that phenylephrine enhances the FR in
both preparations. However, an overall ANOVA of the change scores
revealed that the drug effect was significant only in the 'spinalized'
group (F = 4.13; df = 3,8; p<.05) and not in the 'intact' group (F =
1.28; df = 3,8; n.s.). Subsequent contrasts in the spinalized group
revealed a significant linear trend (F^.^
= 4.41. df = 1,8; p<.05) and
a significant quadratic trend (F^^^^^ = 8.07; df = 1,8; p<.025).
Furthermore, intrathecal treatment with the a^-adrenergic antagonist
WB-4101 (100 ug) following the termination of the 30 minute test
session (at a time when the excitatory effect of phenylephrine was
still apparent) produced a rapid blockade of the effect (data not
shown). Moreover, systemic pretreatment with another a^_adrenergic
antagonist, prazosin, also prevented any sign of phenylephrine
activation. Thus the excitatory effect of phenylephrine on the FR in
spinalized rats is attributable to a^_adrenergic activation.
It should be emphasized, however, that the excitatory effect of
phenylephrine in the spinal rat was very weak in comparison to the
clonidine effect on the FR (Fig. 12). At no time was a robust,
"clonidine-like" effect seen. This finding is difficult to understand,
given that the clonidine-induced facilitation of the FR was blocked by
prazosin (Expt. 2). It is possible that clonidine is facilitating the
reflex by acting through stimulation of some non-adrenergic system, and
that the blockade by prazosin is non-specific. Studies of prazosin
antagonism of drug effects on the FR that are mediated through other
neurochemical systems have not been reported. However, it has been
reported that blockade of serotonin receptors with several putative
antagonists (cyproheptadine, metergoline) failed to influence the
effects of clonidine on the FR in rats (Maj et al., 1976).
Furthermore, the clonidine activation is also blocked by another
a^-adrenergic antagonist (phenoxybenzamine; Austin et al., 1976),
providing further support for the idea that blockade of ct^_adrenergic
receptors is critical. Alternatively, clonidine might be facilitating
the FR not by acting on spinal receptors, but rather by acting through
a peripherally-mediated mechanism (e.g. an a^-adrenergic mediated
pressor effect). However, systemic injection of methoxamine, which
mimics the pressor effect of clonidine (Goodman and Oilman, 1980), did
not produce any activation of the FR in spinalized rats. Furthermore,
Nozaki et al. (1977) reported that intravenous methoxamine produced a
weak, variable (and statistically non-significant) facilitatory effect
on the FR. Austin et al. (1976) reported that clonidine applied
directly to a flexor muscle (the psoas) failed to mimic the excitatory
effect of systemic injection, whereas direct application of clonidine
to the surface of the exposed spinal cord produced a rapid activation
of the reflex. Phenylephrine's lipophobic nature (and hence its
difficulty in crossing lipid membranes) provides another explanation
for its poor efficacy in facilitating the FR. Even with intrathecal
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infusions, the drug may have difficulty in saturating the relevant
receptor sites in the lumbar spinal cord that are necessary for the
a ^-adrenergic mediated activation of the FR to occur.
The original purpose of this experiment was to assess for signs of
a^-adrenergic supersensitivity following spinal transection. Given the
weak nature of the results, it is important to look more closely at
Expt. 5, in which a progressive increase in the excitatory effect of
clonidine was seen at various times after transection.
Ex
ipgriment 1: Effeqts £f re-exposure io halothane anesthetic on the
cJ.onidine induced facilitaton ^ ihe FR in spinalized rats . A
potentially serious objection to the time course study is that the
anesthesia under which the spinal transection was performed might have
had residual effects which would interfere with the expression of the
clonidine-induced facilitation of the FR at early points following
transection. Although, behaviorally, the rats appeared to be normal
very soon (within 5-10 minutes) after the termination of the
anesthesia, subtle residual effects might be occurring. This
experiment was designed to assess for residual effects of the halothane
anesthetic.
Methods . Rats (n=3) were transected as described previously. One and
one-half hours following termination of the operation, the rats were
re-exposed to and maintained under halothane anesthesia for 15 minutes.
Ten minutes following the termination of anesthesia, the rats were
placed in the apparatus and tested in a manner identical to the
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procedure used in Expt. 5. That is, the rats received a 5 minute
baseline, after which they were injected with 0.5 mg/kg clonidine and
tested for an additional 30 minutes.
^^^"J-^^^ discussion . The halothane re-exposure completely prevented
the expression of the clonidine-induced excitation of the FR.
Normally, this facilitation is maximal 2 hours following transection.
The mean change scores (5 minutes pre-injection minus 30 minutes post-
injection) were: 0.2 + .1 (re-exposed group) and 14.2+1.7 (rats not
re-exposed to halothane, data from Expt. 2). There was a statistically
reliable difference between these two groups (t = 6.03; P<.01),
supporting the conclusion that re-exposure to halothane interfered with
the expression of the facilitatory effects of 0.5 mg/kg clonidine on
the FR.
Recently, it has been reported that a brief (5 minute) exposure of
mice to halothane anesthetic produced signs of decreased cerebral
energy metabolism in the brain, some of which still persisted 10
minutes following termination of anesthesia (a time at which the mice
showed behavioral recovery) (McCandless and Wiggins, 1981). Such
changes might contribute to the interfering effects of halothane found
in the present study.
The results of this experiment make the outcome of the time-course
study (Expt. 5) difficult to interpret. It is clear that prior
exposure to halothane can interfere with the expression of the
excitatory effects of clonidine on the FR. Although the present
experiment does not provide a precise quantification of the residual
effects of halothane that might have accounted for the time course
found in Expt. 5, it nonetheless indicates that such residual effects
cannot be ruled out.
These findings emphasize the need to evaluate the effects of
clonidine on the FR following transection in a preparation in which
anesthesia can be ruled out as a confounding factor. One procedure
which could be used to produce a rapid, ' transection-like • blockade of
spinal impulse flow is 'spinal block' with a spinal ly-administered
local anesthetic. The purpose of the next experiment was to use
intrathecally-infused procaine to achieve such a spinal block, and
thereby determine if the excitatory effects of clonidine would be
immediately "unmasked" following rapid cessation of spinal impulse
flow.
Experiment ^: Intrathecal procaine-induced reversal of effects of
clonidine. This experiment was designed to determine if, at a time of
maximal or near-maximal depression of the FR in the intact rats, a
sudden blockade of spinal impulse flow by intrathecally-administered
procaine could produce a shift of the clonidine effect from inhibition
to excitation.
Methods . Reversible spinal block was accomplished by intrathecal
infusion of a 20$ procaine solution. Intrathecal catheters were
constructed as previously described, except that the length of the PE
10 tubing was shorter (5.5 cm), to allow infusion into the thoracic
sub-arachnoid space (determined by dye injection). Three to four days
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following implantation, rats were placed into the test apparatus and
given a 5 minute baseline. They were then injected IP with either
vehicle (n=3) or 2.0 mg/kg clonidine (n=3). and then tested for an
additional 20 minutes. At this point (the time of near-maximal
depression by clonidine), the contents of the intrathecal catheter (4
ul saline) were infused, followed by 1 - 2 ul of procaine. Testing was
carried out for an additional 15 minutes.
Results and discussion
. As seen in the bottom panel of Fig. 13, rats
treated with 2.0 rag/kg clonidine showed a depression from baseline, in
contrast to rats that had been injected with IP vehicle. However, when
the clonidine-injected rats were infused with 1 - 2 ul procaine, there
was a sudden shift of the FR from inhibition to excitation. This
excitation occurred either immediately or within a minute or two
following procaine infusion, and was accompanied by paralysis of the
hindlimbs. The excitatory effect was transient, lasting 4-5 minutes
before the response levels returned to their original low levels. The
decay of the excitation was accompanied by a loss of complete paralysis
(that is, return of muscle tone and/or some spontaneous leg movements).
In contrast, when the vehicle pretreated rats were infused with
procaine, a different response was seen. Following procaine infusion,
the FR showed a rapid, ' transection-like ' decline in response amplitude
to near zero levels (top panel of Fig. 13). During this period of
diminished responsiveness, the rats showed clear hindlimb paralysis.
Recovery from the anesthetic (as indicated by a return of muscle tone
and some movement) was not immediately accompanied by a return to
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baseline, though one rat that was tested for a longer time period did
regain normal levels of responsiveness.
One might argue that the procaine-induced excitation in the
clonidine pretreated rats was due not to an active, clonidine-induced
excitatory process, but rather to a non-specific 'release* from tonic
supraspinal inhibition. However, this argument is refuted by the
results obtained from the vehicle pretreated rats, in which no signs of
excitation following procaine infusion were seen. Rather, these
animals showed an abrupt decline in response amplitude to near zero
levels.
Despite the positive results obtained with acute infusions of
procaine, there were several technical and theoretical problems with
the technique that limited its use. First, although initial pilot work
indicated that prolonged spinal block could be readily achieved, in
practice the exact levels of procaine needed for effective, prolonged
anesthesia proved to be difficult to titrate. Repeated infusions of
procaine often produced respiratory failure, probably due to diffusion
of the anesthetic to respiratory centers in the cervical cord. Some
rats tolerated even larger doses of procaine quite well, though no
clear factor underlying the mixed responses was evident. Furthermore,
depressant effects seen following prolonged administration might be
attributable to diffusion of the anesthetic to the lumbar cord, where
direct interference with the FR circuitry could take place. Second, in
the strictest sense, anesthetic-induced blockade of impulse flow is not
equivalent to the transections produced in previous experiments, since
it involves a chemical, not mechanical, disruption of impulse flow in
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the spinal cord. What is needed is a technique by which a mechanical
transection could be performed wiLthout the interference of a general
anesthetic. In the next experiment, such a technique was used to
determine whether spinal transection can "unmask" an excitatory effect
of clonidine on the FR.
PXP^rlpient IQ.: Spina; ligation-induof^ri reversal effects q£_
c3.on3.diqe iifl il^g jji intact rats .
Methods
.
Under halothane anesthesia, the spinal cord was exposed using
procedures described previously. However, instead of severing the
spinal cord, the following procedure was carried out. The spinal cord
was constantly bathed in saline, to maintain its viability. A suture
thread was inserted into the eye of a curved suture needle. Holding
the sharp end of the needle with hemostats, the blunt end was carefully
passed underneath the spinal cord, and the thread was retrieved with a
pair of fine, pointed tweezers. Care was taken not to put too much
upward pressure on the spinal cord, since this was found to induce some
spinal paralysis. The thread was tied loosely around the cord and the
ends brought up through the incision in the skin. The exposed spinal
cord xvas then covered with a layer of vaseline and gauze. The skin was
sutured shut, and the rat allowed to recover for at least 4-1/2 hours
before testing.
Rats that underwent this operation showed a range of recoveries,
varying from 'poor' (complete or near complete paralysis) to 'fair'
(clear presence of voluntary motor control, but some residual
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motor/muscle tone abnormalities), to 'excellent' (physically
indistinguishable from unoperated rats). Animals in
-poor- condition
were not included in the following study, since they appeared to be
functionally transected.
A test procedure similar to that used in the procaine study (Expt.
9) was used. Rats were given a 5 minute baseline period, injected with
either 2.0 mg/kg clonidine (n=3) or vehicle (n=3), and then were
treated for an additional 20 minutes. At this point, the rats were
mechanically transected by tightening the thread that was tied around
the spinal cord (hereafter referred to as 'spinal ligation').
Following spinal ligation, the FR was measured for an additional 20
minutes. Spinal ligation occurred a minimum of 4-1/2 hours following
exposure to halothane anesthesia.
Results and discussion . Fig. 14 shows the effects of ligation of the
spinal cord in rats that had been treated with either vehicle (open
circles) or 2.0 mg/kg clonidine (closed circles). Prior to ligation,
clonidine produced a depression of the FR relative to the pre-injection
baseline, whereas vehicle injection had little effect. Immediately
following the spinal ligation, all rats showed a transient
(approximately 30 seconds in duration) period of spontaneous flexions
and extensions of the hindlimbs and tail slapping. This phenomenon
corresponds to the kicking reflex that has been reported to occur
following decapitation (referred to as the 'post-decapitation reflex'
or PDR; Pappas et al., 1980). During, and for a few minutes after the
cessation of the PDR, the FR was greatly augmented in both groups.
^
However, whereas vehicle treated groups showed a rapid and precipitous
decline to near zero levels of responding (like typical transected or
procaine-treated rats), the clonidine treated rats' FR remained
elevated throughout the entire post-transection test period. This
elevation was relative to both the immediate pre-transection level and
also relative to the original baseline level. Thus, spinal ligation
produced an immediate shift in the effect of clonidine from inhibition
to excitation. Preliminary data indicates that 1.0 mg/kg pretreatment
with the
-adrenergic antagonist prazosin 1/2 hour before testing
attenuated (but did not block) the excitation induced by 2.0 mg/kg
clonidine. The lack of complete blockade by prazosin (unlike the
findings of Expt. 2) might be attributable to the fact that a high dose
(2.0 mg/kg) of clonidine was used in the present experiment
(alternatively, a longer pretreatment time might be warranted, since
This transient period of excitability could be attributed to either a
release from a tonic, supraspinal inhibition (Karaut and Sheth, 1971)
or it could be due to a transection-induced release of spinal
neurotransmitters (i.e. the monoamines) that are facilitatory to
spinal reflexes. An argument against the former is the finding in
the previous experiment that intrathecal procaine failed to produce a
similar, transient hyperexcitability in vehicle treated rats, but
rather caused an abrupt decline in response amplitude. Currently,
there is no direct proof for the latter hypothesis. However, it has
been shown that immediately after peripheral axons have been cut or
crushed, they fire off a high-frequency repetitive volley ('injury
discharge'). This discharge lasts for seconds, or at most minutes,
after which the fibers fall silent. The fibers are still
electrically excitable, and may at later times, take on a spontaneous
discharge of their own (Kirk, 1974; Wall et al., 1974). It would
thus not be surprising to find signs of enhanced noradrenergic
activity (i.e. increased release) in the lumbar cord shortly
following transection.
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prazosin does not readily pass the blood-brain barrier). Nonetheless,
a partial attenuation is consistent with the notion that clonidine is,
at least in part, exerting its effects through an activation of
-adrenergic receptors.
The results of Expt. 5 suggested that clonidine' s excitatory
effect on the FR was maximal at two hours following transection.
However, the last three experiments indicate (1) that the lack of an
excitatory clonidine effect at early times following transection was
attributable to the interfering effects of the halothane anesthesia,
and (2) that spinal block or ligation immediately unmasks an
-adrenergic mediated excitatory effect of clonidine. Nevertheless,
if there is a progressive augmentation of the clonidine excitation
following transection, then this should be manifest by a greater
response to clonidine at two hours following 'spinal ligation' than at
an early point after 'ligation'.
Experiment H: Effects of clonidine on the FR 15. minutes or 2. hours
following spinal ligation . The purpose of this experiment was to
evaluate the effects of 2.0 mg/kg clonidine at either 15 minutes or 2
hours following spinal ligation.
Methods . Rats were prepared as described in the previous study. Four
hours following initial surgery, rats were spinally ligated and either
15 minutes or 2 hours later, placed in the test apparatus. Following a
5 minute baseline, rats were injected with 2.0 mg/kg clonidine (IP) and
tested for an additional 30 minutes.
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Resiat^ and di^filissi^. At the time of testing, all rats showed
complete hindlimb paralysis typical of spinalized rats. Following
clonidine administration, both groups showed a marked enhancement of
the FR. The change scores (5 minutes pre-injection minus 30 minutes
post-injection) ± standard error of the mean were: 17. 3 ± 3.7 (group
ligated 15 minutes before testing) and 22.6 ± I.9 (group ligated 2
hours before testing). An independent t-test revealed no significant
difference in these change scores between groups (F = 1.28, df = 4,
n.s. )
.
Ep^periment IE: ^H-prazosin^ ^H-donidine binding M 15. minutes Z
hours fo3.3Owi^g spiqal ligation. A supraspinal hypothesis could be
invoked to explain the immediate shift in the effects of clonidine from
inhibition to excitation following transection (spinal ligation). If
supersensitivity does rapidly occur, then one might expect to see
changes in a ^-adrenergic binding, at either 15 minutes or 2 hours
following spinal ligation. The purpose of the present experiment was
to evaluate this possibility.
Methods
. Twelve rats with threads tied around their spinal cords were
prepared as before. Four hours following the operation, the cord was
tied off (spinal ligation). Rats were sacrificed either 15 minutes
(n=3) or 2 hours (n=3) later, and their lumbar cords were dissected out
and frozen at -70°C. In addition, a 'sham-operated' group (n=3), in
which threads were implanted but transection was not carried out, and
an 'untreated group' (n=3; naive rats taken directly from the animal
room) were similarly sacrificed. One day later, the lumbar cord
samples were prepared for combined ^H-prazosin/Bn-clonidine assay
(procedure described in general methods section). However, a Scatchard
analysis was not carried out. Rather, specific binding was measured in
tissue from each individual animal in the presence of a single
concentration of either ^H-prazosin (1.0 nM) or ^K-clonidine (H.O nM).
Similar procedures to those previously described were used to perform
the assays.
ResuIM aM discussion
.
Fig. 15 shows that the mean specific binding
of H-prazosin or ^H-clonidine was not different across the four
groups. If anything, the 2 hour transected ras showed a slight
decrease in ^H-prazosin binding and a slight elevation in ^H-clonidine
binding. However, an overall one-factor ANOVA revealed no change in
^H-prazosin binding (F = 1.02; df = 3,8; n.s.) or in ^H-clonidine
binding (F = .45; df = 3,8; n.s.). Mean binding values for individual
groups were: unooerated controls - 63.1 ; sham-ooerated - 57.4; 15
iq^^ute firoup - 57.1 ; Z hour group - 49.2 fmole/mg protein (^H-prazosin
binding) ; and unooerated controls - 91.0; sham-ooerated - 89. 1 ; 15
minute group - 98.7; 2 hour group - 105.9 fmole/mg protein (^H-
clonidine binding).
Thus, using the 'spinal ligation' procedure in which halothane
anesthesia is less likely to be a confounding factor, changes in
a^-adrenergic and a2-adrenergic binding were not seen. The fact that
no change occurred at the 2 hour time point was surprising, since the
previous binding experiments (Expt. 6) indicated that there were
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increases in the number of ^H-prazosin binding sites. There are no
obvious explanations for the discrepancy between these two experiments.
Perhaps the changes found in the previous experiment are attributable
to an interaction between the halothane anesthetic and the transection
procedure. Nonetheless, the findings of the present experiment do
indicate that changes in a^-adrenergic and a2-adrenergic receptor
binding are not necessary for the occurrence of the shift in the effect
of clonidine on the FR from inhibition in the intact rat to excitation
in the transected rat.
The data gathered thus far indicate that, in the normal rat,
clonidine produces an inhibition of the FR that is, at least in part,
mediated by an activation of a^-adrenergic receptors. Furthermore,
some supraspinal influence (either an inhibitory system activated by
clonidine or another, independent system that is tonically active)
prevents clonidine from expressing an a ^.adrenergic mediated activation
of the FR at the spinal level. Transection produces a 'release' from
this inhibitory influence, allowing the excitatory effects to occur.
The task of determining the locus (loci) of the supraspinal modulatory
systems would be greatly facilitated if one could evaluate the effects
of clonidine in a 'reduced' preparation. Decerebration neural ly
isolates the caudal brainstem from the forebrain, allowing one to rule
out forebrain contributions to observed effects of drugs on behavior.
Experiment H: Effects of clonidine m Ihg. F£ in acutelv-decerebrated
rats . The purpose of this experiment was to determine if the effects
of clonidine on the FR were altered in the acutely-decerebrated rat.
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Methods .
Decerebratlon
.
Rats were anesthetized with halothane and placed in
Kopf stereotaxic instrument. The nose bar was set at
-3.5. A midline
incision was made over the skull and the skin and fascia were
retracted. A hole was made with a large burr drill at the farthest
lateral point on the top of the skull, such that the center of the hole
was 1.5 cm anterior to lambda. Decerebrations at this level extend
from the splenium of the corpus callosum down to the mammillary bodies.
To decerebrate, the tip of a retractable wire knife (see Davis and
Gendelman, 1977, for detailed construction procedure) was lowered into
the hole and the wire extended to its full 12 mm length. It was then
lowered until it reached the base of the brain. The knife was then
moved back up until it touched the top of the skull and then pulled
straight up until it came out of the skull. This procedure caused the
wire to deflect from its normal angle, as it slid along beneath the top
surface of the skull, and allowed the most inaccessible areas directly
below the top of the skull to be transected as well. By withdrawing
the knife quite slowly at this step, it was usually possible to avoid
injury to the sagittal sinus.
Testing . Two hours following decerebration, the rats were placed in
the test apparatus, and a 5 minute baseline period was taken. Rats
were then injected IP with either 2.0 mg/kg clonidine (n=3) or vehicle
(n=3) and tested for an additional 30 minutes. At the end of testing,
rats were sacrificed and their brains removed for histology.
onic
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Results and discussion. Following deoerebration, the rats showed t
extension of the hindlimbs, characteristic of 'decerebrate rigidity'.
Fig. 16 shows the effects of either 2.0 mg/kg clonidine (closed
circles) or vehicle (open circles) on the FR in decerebrate rats.
Clonidine still depressed the reflex in the decerebrate animal. An
independent t-test comparing the change scores (30 minutes post-
injection minus 5 minutes pre-injection) revealed a significant
difference between the vehicle and clonidine injected groups (t = 2.7;
df = 4, p<.05).
These data indicate that, even in the decerebrate preparation,
clonidine exerts a potent depressant effect on the FR, with no sign of
excitation. Thus, the structure (or structures) that mediates the
depressant effect of clonidine and that prevents a clonidine-induced
excitatory effect from being expressed is present in the caudal
brainstem.
CHAPTER 3
GENERAL DISCUSSION
The results of these experiments may be summarized as follows:
tot. 1 showed that clonidine produced a dose-related depression of the
FR in intact rats, whereas it produced a dose-related excitation of the
FR in spinally-transected rats. Thus, clonidine was found to depress
the FR just as it does a wide range of other behaviors, provided the FR
was measured in the intact rat. Exot . Z showed that the excitatory
effects of clonidine on the FR in spinally-transected rats were
mediated by an activation of
-adrenergic receptors, since the
-adrenergic antagonist prazosin was more effective in blocking the
effect than was the a^-adrenergic antagonist piperoxane. Conversely,
the clonidine-induced depressant effect on the FR in intact rats was
attenuated by piperoxane, but not affected by prazosin pretreatment,
supporting the conclusion that this effect was mediated by an
activation of a2-adrenergic receptors. Expt . 3. showed that
intraventricular, but not intrathecal administration of the
a2-adrenergic agonist oxymetazoline was effective in depressing the FR
in intact rats, and this effect was attenuated by pretreatment with the
a2-adrenergic piperoxane. Expt
. A. These data support the notion that
the clonidine stimulation of supraspinal a2-adrenergic receptors was
responsible for exerting its depressant effect on the FR in the intact
rat. Expt . 5. showed that the facilitatory effect of clonidine on the
FR in spinalized rats increased in magnitude as a function of time
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following transection, with a maximal activation occurring at two hours
following transection. These data were interpreted as being consistent
wth the notion that a rapid development of supersensitivity, rather
than a release from supraspinal inhibition, underlied the shift of the
clonidine effect from inhibition to excitation in the transected rat.
tot. L showed that at two hours following transection (a time of
maximal excitation of the FR in the spinalized rat), there was an
increase in the number of a^.adrenergic receptor sites in the lumbar
spinal cord. This biochemical index was consistent with the
development of
-adrenergic supersensitivity, Ej^t. 1 found that
intrathecal administration of the a^-adrenergic agonist phenylephrine
produced only a weak excitatory effect in spinalized rats and little,
if any effect in intact rats. These data did not support the
hypothesis that
-adrenergic supersensitivity developed following
transection. Ey^pt. 1 showed that the halothane anesthetic used in the
operations was capable of interfering with the expression of the
clonidine excitatory effect on the FR, thus making the results of Expt .
5l ambiguous. Expt . S. found that a blockade of spinal impulse flow with
intrathecal procaine caused an immediate shift in the effect of
clonidine from inhibition to excitation, consistent with the idea that
spinal transection eliminates a supraspinal, inhibitory influence that
normally prevents the a ^-adrenergic excitatory effect of clonidine from
being expressed. Expt . 1
0
showed that 'spinal ligation' in intact,
behaving rats similarly produced an immediate shift in the effects of
clonidine from inhibition to excitation. Expt . 1
1
showed that the
excitatory effects of clonidine in rats that had undergone prior spinal
ligation were near maximal whether the rats were tested 15 minutes or 2
hours later. These data were again consistent with a 'release'
hypothesis, tot. ^ 3howed that a^-adrenergic and a^-adrenergic
receptor binding in the spinal cord did not change in rats that had
been spinally-ligated two hours or fifteen minutes before. The lack of
a significant binding change provided further evidence against the
supersensitivity hypothesis, and indicated that the binding changes
seen in L might be related to an anesthetic-transection
interaction, tot. 13. showed that clonidine still depressed the FR in
the decerebrate rat, indicating that the mechanism that prevents
clonidine induced excitation from being expressed does not require
forebrain structures.
The overall aim of the proposed studies was to gain an
understanding of why clonidine acts like an a^.adrenergic agonist to
excite the FR in spinally-transected rats when, in other behavioral
paradigms (e.g. the acoustic startle reflex) it exerts 0'2-mediated
depressant effects. Phenomenologically, the resolution to this paradox
is clear: the
-adrenergic excitatory effect of clonidine was seen
only in rats that were spinally-transected (either physically or
functionally, with local anesthetic-induced spinal block). When
injected into Intact rats, clonidine produced a potent depression of
the FR, v/hich was attributable to the activation of supraspinal
o(2-adrenergic receptors. Thus, in the intact rat, clonidine produced
an effect on the FR qualitatively similar to that seen on acoustic
startle and other behaviors.
These results suggest that caution should be exercised when
interpreting pharmacological data gathered using the spinalized
preparation, in that qualitatively different drug effects may be seen
in the spinalized vs. intact organism. Certainly, the rationale for
employing spinalization is reasonable: cutting the spinal cord
effectively eliminates any contribution of supraspinal actions of
systemically-administered drugs. However, alternative methods for
localizing drug action to the spinal cord (i.e. the intrathecal
technique) may provide information that is more relevant to
understanding spinal neurochemical modulation in the intact organism.
In this regard, almost all of the evidence that has been cited in
support of clonidine's a^-adrenergic agonist property has utilized the
spinalized preparation. Drug antagonism studies (reported previously
and in the present study) clearly show that clonidine's facilitatory
effect is due to its spinal a ^-adrenergic agonist property. Yet this
property is evident only when the influence of supraspinal structures
is eliminated. Why doesn't stimulation of spinal a ^-adrenergic
receptors by clonidine produce excitation of the FR in the intact rat?
The initial hypothesis entertained was that spinalization-induced
disruption of descending impulse flow in noradrenergic neurons produced
a rapid "denervation supersensitivity" in spinal a ^-adrenergic
receptors that accentuated the a ^-agonist properties of clonidine.
Indeed, receptor binding parameters and the time course for the onset
of clonidine's facilitatory effect supported this hypothesis. However,
several subsequent findings (primarily the lack of functional evidence
for supersensitivity following intrathecal phenylephrine
administration) strongly argued against a supersensitivity explanation.
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Nevertheless, other studies have provided evidence for the long-
term development of supersensitivity following transection. Nozaki et
al. (1978) found that the effects of the
-adrenergic agonist
methoxamine on the FR were greatly enhanced in rats that had been
transected for two months (^s. one day). The effect of methoxamine was
blocked by pretreatment with the a^.^^renergic antagonist
phenoxybenzamine, supporting the conclusion that the effect was
attributable to an activation of a^.adrenergic receptors. Nygren and
Olsen (1976) used a different approach to demonstrate the development
of
-adrenergic supersensitivity in spinal receptors. These authors
found that prior depletion of spinal NE with intracisternally-
administered 6-hydroxydopamine enhanced the excitatory effect of
clonidine on the FR in acutely-spinalized rats. Thus, either long-term
spinalization or long-term depletion of spinal NE produced clear signs
of spinal
-adrenergic supersensitivity. In another behavioral
paradigm, the acoustic startle response, an enhanced excitatory
response to phenylephrine has been found following chronic (a week or
more) depletion of spinal NE by means of intrathecally-administered
6-hydroxydopamine. Furthermore, the enhanced response to phenylephrine
correlated highly with the increase in the number of
-adrenergic
binding sites in the lumbar spinal cord, as measured with [^H]-
prazosin. Thus, in this case, changes in receptor binding reflected
functional signs of supersensitivity (Astrachan, Davis and Gallager, in
press).
In lieu of a supersensitivity explanation, the bulk of the
evidence supports the hypothesis that, in the intact rat, clonidine
activation of supraspinal a^-adrenergio receptors engages an inhibitory
system that depresses the FR and prevents the expression of clonidine's
spinal a^-adrenergic excitatory effects. Spinal ligation or spinal
block removes the supraspinal inhibitory influence, allowing the
immedi ^t-.p expression of the <?ninflln sp a a ^ -adrenergic excitatory effects of
clonidine. What evidence is there for the existence of a supraspinal
inhibitory system with which clonidine might interact?
In a series of now-classic studies, Magoun and Rhines investigated
the effects of electrical stimulation of different areas in the
brainstem reticular formation on spinal reflex activity. In addition
to finding areas that, when stimulated, produced an excitation of
spinal reflexes, they noted that stimulation of the ventro-medial
bulbar reticular formation produced a profound inhibitory influence on
spinal reflexes (Magoun and Rhines, 19^6). This stimulation inhibited
extensor and flexor reflexes, as well as inhibiting reflex activity
initiated by stimulation of supraspinal structures, such as the motor
cortex. The inhibition produced by stimulation was present following
complete transection of the rostral medulla, indicating that a direct
descending pathway was involved. Recently, fast-conducting axons from
the ventro-medial reticular formation have been shown to descend into
the spinal cord via the dorsolateral funiculus (Field and Basbaum,
1978). In addition to the classic "depressor area" of Magoun and
Rhines, another area, designated the "raagnocellular tegmental field"
(located adjacent to the raphe nuclei) has been found to exert a
depressant effect on somatic reflexes (Engberg, Lundberg and Ryall,
1968). This area gives rise to axons that descend into the spinal cord
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via the ventrolateral funiculi. Whereas the ventromedial reticular
formation exerts its influence almost exclusively on cranial motor
nuclei and ventral horn motor neurons, the tegmental field appears to
exert more widespread influences, especially in the dorsal horn (Field
and Basbaum, 1978)
.
Postural atonia (i.e. suppression of spinal postural reflexes) can
be produced (1) spontaneously in chronic decerebrate animals; (2) by
injection of an anticholinesterase in acute decerebrates; and (3)
during REM sleep in intact animals (cf. Porapeiano and Hoshino, 1976).
This suppression of reflex activity has been attributed to the
activation of the bulbospinal inhibitory system originating in the
gigantocellular tegmental field ("FTG"), one of the "depressor areas"
just described. Furthermore, Pompeiano and Hoshino (1976) suggested
that a dynamic interaction exists between the nucleus locus
coruleus/subcoeruleus and the FTG, whereby increased noradrenergic cell
firing inhibits the FTG, and decreased noradrenergic activity releases
the FTG from inhibition (thus causing it to become active and produce
reflex depression). Since cholinergic neurons are found in the FTG, it
was proposed that activation of these neurons (either by administration
of an anticholinesterase or by reduced noradrenergic activity) produced
postural atonia. The authors' hypothesis was supported by good
correlations between single cell activity (in the locus
coeruleus/subcoeruleus and FTG) and periods of postural atonia induced
by the anticholinesterase eserine. That is, high FTG activity (and low
locus coeruleus activity) corresponded to atonia, whereas the reverse
pattern accompanied recovery. Interestingly, somatosensory stimulation
99
(which is known to activate the locus coeruleus) reversed eserine-
induced atonia.
This work was carried out in cats, though it is possible that such
a relationship exists in the rat as well. A "NE-FTG" interaction might
shed light upon the mechanism underlying the depressant effect of
clonidine in the intact rat. Specifically, if the locus coeruleus
tonically inhibited the FTG, then reduction of noradrenergic neuronal
firing following clonidine administration would be expected to
"release" the FTG, allowing it to exert a depressant effect on spinal
reflex activity. Such a relationship would lead to the predictions
that
:
1. Administration of eserine into the FTG would mimic the
depressant effect of systemic clonidine on the FR in the
intact rat.
2. Lesions of the locus coeruleus/subcoeruleus would depress the
FR (by disinhibiting the FTG).
3. Clonidine administration to a locus coeruleus/subcoeruleus
lesioned rat would not "unmask" an excitatory effect on the FR
(since the descending inhibitory system would be tonically
engaged).
4. Lesions of the FTG (or its output) would produce a
spinalization-like "unmasking" of the a ^-adrenergic excitatory
effect of clonidine on the FR.
In support of this overall schema, (1) it was found that
depression of the FR in intact rats became evident at lower doses than
did excitation in the spinalized rats; and (2) preliminary data
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indicates that bilateral lesions of the locus coeruleus/subcoeruleus
produce the predicted results (a depression of the FR, and no
excitatory effect following clonidine administration). However, the
most compelling evidence would be the "unmasking" of clonidine 's
excitatory effect following lesions to the FTG.
The problem with this proposed mechanism is that, at high doses,
clonidine would be predicted to act on post-synaptic a ^-adrenergic
receptors to inhibit the FTG (and thus reduce or reverse the depression
of the FR). At the doses tested in the current study, there was no
evidence for such a reversal. (Perhaps a very high dose of clonidine
would produce an excitatory effect in the intact rat. ) Another
explanation is that clonidine, at high doses, might be having
depressant effects mediated through other neurotransmitter receptors,
such as histamine (Sastry and Phillis, 1977).
Alternatively, clonidine might be stimulating supraspinal
a2-adrenergic receptors that are located other than presynaptically.
Recent work indicates that a large percentage of the total number of
a2-adrenergic receptors are located postsynaptically to noradrenergic
neurons (Dausse et al., I98I; U'Pritchard et al., 1978). Thus,
clonidine could activate (through a post-synaptic ot^-adrenergic
receptor) a depressor system that would account for the observed
effects on the FR. Importantly, high doses of clonidine would not be
expected to produce a 'shift' of the effects of clonidine.
Furthermore, direct infusion of oxymetazoline into the depressor area
in intact rats would be predicted to mimic the depressant effects of
systemic clonidine.
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If lesions Of a particular inhibitory area produced a "release" of
the excitatory effects of clonidine on the FR, then it would be
interesting to see if other behaviors which are normally inhibited by
clonidine (e.g. locomotor activity, startle) would now show an
ot^-mediated excitation.
With regard to locomotor activity, Grillner and his colleagues
(Grillner, 1975; Forssberg and Grillner, 1973) have shown that
clonidine administered to spinally-transected cats suspended above a
moving treadmill produces patterned locomotor movements. Since this
activation was blocked by phenoxybenzamine, the authors concluded that
stimulation of noradrenergic receptors in the spinal cord activates the
pattern generator for locomotion. Furthermore, the clonidine-induced
stepping is similar to the locomotor activation seen when a region of
the brainstem (designated the "mesencephalic locomotor region", or MLR)
is electrically-stimulated in low-decerebrate cats (which normally do
not spontaneously locomote). Since the locomotion induced by MLR
stimultion is blocked by phenoxybenz amine, and since the MLR is
closely-situated anatomically to the nucleus locus coeruleus (Steeves
et al., 1980), the authors concluded that MLR stimulation produced
locomotion by releasing NE in the spinal cord. Curiously, however, it
has not been reported whether clonidine administration in the low-
decerebrate preparation produces locomotor stimulation. Given other
reports that the drug depresses locomotion in intact rats (as well as
exerting general depressant effects on behavior), it would not be
surprising to find that clonidine was ineffective. If this were the
case, one might postulate that MLR stimulation was, in addition to
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releasing spinal NE, also disengaging an independent descending
inhibitory syste. that would normally prevent a^-adrenergic stimulation
in the spinal cord from having excitatory effects on locomotor
behavior.
A recent report has shown that a developmental change to the
locomotor effects of clonidine takes place (Reinstein and Issacson,
1977). Prior to postnatal day 7, rats show a marked stimulation
following clonidine administration, followed thereafter by a shift in
the response to inhibition. This finding is consistent with the notion
that an inhibitory system which prevents the spinal ct^
.adrenergic
effects of clonidine from being expressed is not functional at early
ages. If this were the case, then it would be predicted that intact
baby rats would show an excitatory FR response following clonidine
administration. That is, functionally, baby rats should respond to
clonidine like spinally-transected adults.
Beyond lesion studies, it would be of interest to investigate
pharmacological and, possibly, environmental conditions which would
similarly produce a "release" of clonidine 's
-adrenergic effect.
Pharmacological conditions have been reported in which clonidine
produces a^-adrenergic mediated excitatory effects. For example,
clonidine was found to depress tactile startle when administered alone
(Geyer, 1978), but when given in combination with d-amphetamine, it
produced a potentiation of the excitatory effect of amphetamine
(Handley and Thomas, 1977). This potentiation was blocked by the
-adrenergic antagonist phenoxybenzamine, supporting the conclusion
that an activation of -adrenergic receptors was involved. In other
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studies, clonidine has been found to potentiate the excitatory effects
of apoznorphine on locomotor activity (Strombom, 1975) and, again, this
effect was blocked by phenoxybenzamine. Apomorphine and d-amphetamine
share the common property of enhancing dopaminergic transmission
(apomorphine, by a direct agonist action at dopamine receptors, and d-
amphetamine, by increasing release and decreasing uptake into the
presynaptic terminal (see Groves and Rebec, 1976)). Thus, in the case
of locomotion and tactile startle, an enhancement of dopaminergic
transmission would appear to produce a shift in the effects of
clonidine from inhibition to an a ^.mediated excitation. It would be of
interest to see if a similar shift on the FR would be seen if
apomorphine was administered together with clonidine. Such a shift
would be consistent with the idea that increasing dopaminergic
transmission in the brain "turns off" a tonically-active brainstem
inhibitory system, which in turn enables clonidine to exert an
excitatory behavioral stimulation through an activation of spinal
a ^-adrenergic receptors.
Both dopaminergic (Antelman and Caggiula, 1976) and noradrenergic
(Weiss et al., 1981) systems have been implicated in mediating an
organism's behavioral response to stress-inducing stimuli. The
ultimate behavioral outcome when an animal is exposed to stress in all
likelihood represents the dynamic interaction of both systems. Given
the schema described in the preceding paragraphs, one could postulate
that in the presence of an aversive stimulus, an activation of
dopaminergic neurons could disengage a brainstem inhibitory system,
thus "unmasking" the effects of a concomitant release of spinal NE.
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The resulting behavioral response (facilitated reflexes/locomotion)
would represent an important example of an interaction between
supraspinal and spinal systems in mediating an integrated, adaptive
response.
SUMMARY
1. Clonidine depresses the flexor reflex in intact rats through a
stimulation of supraspinal cx^.adrenergic receptors that are located
in the caudal regions of the brainstem.
2. Clonidine facilitates the flexor reflex in spinalized rats through
a stimulation of spinal
-adrenergic receptors.
3. In the intact rat, the depressant effect of supraspinal
a2-adrenergic stimulation "overrides" the excitatory effect of
spinal a-, -adrenergic receptor stimulation.
4. Spinalization removes the influence of the supraspinal
a2-adrenergic system, allowing the excitatory effect of spinal
-adrenergic receptor stimulation to be expressed.
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Table J.. Comparative effects of various drugs on the flexor and
startle reflexes.
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TABLE 1
EFFECT ON EFFECT ON
^^^^^ FLEXOR REFLEX STARTLE REFLEXACTION DRUG (SYSTEMIC INJECTION) (INTRATHECAL INJECTION)
INCREASE
SEROTONERGIC
TRANSMISSION
d5-HT
LSD
MESCALINE
PARA-CHLOR-
AMPHETAMINE
INCREASE
INCREASE
INCREASE
INCREASE
INCREASE
INCREASE
INCREASE
INCREASE
INCREASE
DOPAMINERGIC APOMORPHINE NO CHANGE NO CHANGE
TRANSMJSSION
DECREASE
GLYCINERGIC STRYCHNINE INCREASE INCREASE
TRANSMISSION
DECREASE
GABAERGIC PICROTOXIN INCREASE INCREASE
TRANSMISSION
INCREASE d-AMPHETAMINE INCREASE INCREASE
NORADRENERGIC METHOXAMINE INCREASE INCREASE
TRANSMISSION PHENYLEPHRINE
CLONIDINE INCREASE INCREASE
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Table 2. Effects of vehicle or 10 mg/kg piperoxane (I. P.)
pretreatment on vehicle or oxymetazoline (intraventricular) treatment.
Data are expressed as mean change scores (30 minutes post infusion
minus 5 minutes pre-infusion) + S.E.M.
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TABLE 2
Intraventricular Treatment
Vehicle Oxymetazoline
vehicle
Intraperitoneal
Pretreatraent
piperoxane
2.3 ± 1.1 -4.3 ±1.1
-1.3 ± .9 1.2+ .7
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Fig. 1. Mean amplitude flexor reflex following i.p. injection of
0.5 mg/kg clonidine (left panels) or vehicle (right panels) in
spinalized (n=l8, top panels) or intact (n=27, lower panels) rats.
Three stimulus intensities (60v, 30v, 15v) were used.
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Fig. 2. Mean change scores (clonidine minus saline) for rats
treated with clonidine (.007 - 2.0 mg/kg, i.p.) or vehicle in
spinalized (upper panel) or intact (lower panel) rats.
129
130
Fig. 3. Mean amplitude flexor reflex following treatment vfith
clonidine (.007 - 2.0 mg/kg, i.p.) or vehicle in spinalized (closed
circles) or intact (open circles) rats. Each point represents the
average across the three stimulus intensities.
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Fig. 4. Mean amplitude flexor reflex following vehicle (leftpanels), piperoxane (middle panels) or prazosin (rJghrpaneLpretreatment and 0.5 mg/kg (i.p.) olonidine (closed circles) or vehicle
pane'Lr^a s"^
spinalized (upper panels) or in ac? (Zll"
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Fig. 5. Mean change scores (30 minutes post treatment minus 5
minutes pretreatment ) for vehicle, piperoxane, or prazosin pretreated
spinalized (top row) or intact (bottom row) rats.
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Fig. 6. Mean change scores (30 minutes post-injection minus 5
minutes pre-injection) following intraventricular (closed circles) or
intrathecal (open circles) infusion of oxymetazoline (e.25 ug - 50 ug)
or vehicle in intact rats.
137
-20 ' ' ' 1 I—
0 3.1 12.5 50.0
DOSE OXYMETAZOLINE ifiq
)
138
^
Fig. 7. Mean change scores (30 minutes post-injection minus 5minutes pre-injection) following treatment with 0.5 mg/kg (i.p )
clonidine in rats spinal ized 10 minutes, 30 minutes, 2 hours, or 6hours before testing (n=3 in each group).
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Fig. 8. Scatchard analysis of -^H-prazosin binding in rats that
were either spinalized (closed circles) or exposed to anesthetic (open
circles) two hours before sacrifice.
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Fig. 9. Scatchard analysis of ^H-clonidine binding in rats that
were either spinalized (closed circles) or exposed to anesthetic (open
circles) two hours before sacrifice.
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Fig. 10. Scat chard analysis of ^H-prazosin binding in rats thatwere either spinalized (low- thoracic, closed circles) or exposed to
anesthetic (open circles) two hours before sacrifice.
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Fig. 11. Mean change scores (30 minutes post-injection minus 5
minutes pre-injection) following intrathecal infusion of phenylephrine
(25 - 100 ug) or vehicle in spinalized (closed circles) or intact (open
circles) rats (n=3 in each group).
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Fig. 12. Comparison of effects of intrathecal phenylephrine with
i.p. clonidine (0.5 mg/kg, data from Expt. 1).
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Fig. 13. Mean amplitude flexor reflex following intrathecal
procaine in rats pretreated wih 2.0 mg/kg clonidine (i.p.,, lower
panel) or vehicle (upper panel) (n=3 in each group).
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Fig. 14. Mean amplitude flexor reflex following spinal ligationin rats pretreated with 2.0 mg/kg clonidine (i.p., lower panel) or
vehicle (upper panel) (n=3 in each group).
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Fig. 15. -^H-prazosin (upper panel) and ^H-clonidine (lower panel)
binding in rats that were untreated, sham-operated but not ligated,
ligated 15 minutes before sacrifice, or ligated 2 hours before
sacrifice (n=3 in each group).
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Fig 16. Effects of 2.0 mg/kg clonidine (closed circles) or
vehicle (open circles) in rats decerebrated two hours before testing(n=3 in each group).
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